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ABSTRACT 
Initially identified as stress activated protein kinases (SAPKs), the c-Jun N-
terminal kinases (JNKs) are currently accepted as potent regulators of 
various physiologically important cellular events. Named after their 
competence to phosphorylate transcription factor c-Jun in response to UV-
treatment, JNKs play a key role in cell proliferation, cell death or cell 
migration. Interestingly, these functions are crucial for proper brain 
formation. The family consists of three JNK isoforms, JNK1, JNK2 and JNK3. 
Unlike brain specific JNK3 isoform, JNK1 and JNK2 are ubiquitously 
expressed. It is estimated that ten splice variants exist. However, the detailed 
cellular functions of these remain undetermined. In addition, physiological 
conditions keep the activities of JNK2 and JNK3 low in comparison with 
JNK1, whereas cellular stress raises the activity of these isoforms 
dramatically. Importantly, JNK1 activity is constitutively high in neurons, yet 
it does not stimulate cell death. This suggests a valuable role for JNK1 in 
brain development, but also as an important mediator of cell wellbeing.  
The aim of this thesis was to characterize the functional relationship 
between JNK1 and SCG10. We found that SCG10 is a bona fide target for JNK. 
By employing differential centrifugation we showed that SCG10 co-localized 
with active JNK, MKK7 and JIP1 in a fraction containing endosomes and 
Golgi vesicles. Investigation of JNK knockout tissues using phosphospecific 
antibodies recognizing JNK-specific phosphorylation sites on SCG10 (Ser 
62/Ser 73) showed that phosphorylation of endogenous SCG10 was 
dramatically decreased in Jnk1-/- brains. Moreover, we found that JNK and 
SCG10 co-express during early embryonic days in brain regions that undergo 
extensive neuronal migration. Our study revealed that selective inhibition of 
JNK in the cytoplasm significantly increased both the frequency of exit from 
the multipolar stage and radial migration rate. However, as a consequence, it 
led to ill-defined cellular organization. Furthermore, we found that 
multipolar exit and radial migration in Jnk1 deficient mice can be connected 
to changes in phosphorylation state of SCG10. Also, the expression of a 
pseudo-phosphorylated mutant form of SCG10, mimicking the JNK1-
phopshorylated form, brings migration rate back to normal in Jnk1 knockout 
mouse embryos. Furthermore, we investigated the role of SCG10 and JNK in 
regulation of Golgi apparatus (GA) biogenesis and whether pathological JNK 
action could be discernible by its deregulation. We found that SCG10 
maintains GA integrity as with the absence of SCG10 neurons present more 
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compact fragmented GA structure, as shown by the knockdown approach. 
Interestingly, neurons isolated from Jnk1-/- mice show similar characteristics. 
Block of ER to GA is believed to be involved in development of Parkinson’s 
disease. Hence, by using a pharmacological approach (Brefeldin A 
treatment), we showed that GA recovery is delayed upon removal of the 
drug in Jnk1-/- neurons to an extent similar to the shRNA SCG10-treated 
cells. Finally, we investigated the role of the JNK1-SCG10 duo in the 
maintenance of GA biogenesis following excitotoxic insult. Although the GA 
underwent fragmentation in response to NMDA treatment, we observed a 
substantial delay in GA disintegration in neurons lacking either JNK1 or 
SCG10.   
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ND  neurodegenerative diseases  
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NMDA       N-methyl-D-aspartate  
NMDAR    NMDA receptor  
NRS            neural restrictive silencer  
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PFA           paraformaldehyde 
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INTRODUCTION 
The fundamental cellular unit of our nervous system is a neuron. It consists 
of soma, many thin extensions termed dendrites and an “output” neurite 
called an axon. In the brain, we have roughly 100 billion neurons, which 
provide approximately 100 trillion interneuronal connections. In addition, we 
have several times as many supporting cells. This is why the brain, in its 
complexity, is one of the most spectacular biological creations. Often it is 
described as the last frontier of biology. Neurons are significantly larger than 
non-neuronal cells. Along with size, their distinctive cell shape gives rise to 
particular requirements for neuronal cells. They strongly rely on protein and 
organelles transport from cell body to the axon and dendrites which makes 
them unique compared to other cell types. The Golgi apparatus and 
centrosome placement marks the destiny of proximal neurites. The extension 
of neurites, in turn, requires the continuous flow of membranes and 
microtubules. The Golgi and centrosome serve as the first source of those 
building blocks. In addition, they play a crucial role in the delivery of axonal 
and dendrite destined molecules.  
Modern neuroscience faces the difficult task of finding answers to a wide 
array of questions ranging from the development of the nervous system, its 
organization, and the development of behavior. With this comes the 
challenge of combining these pieces of diverse knowledge to produce a clear 
understanding of the brain structure, but also most importantly, its function.   
The family of stress-activated protein kinases (SAPKs/ JNKs) has already 
previously been shown to be involved in various life-threatening diseases 
like heart disorders, diabetes and stroke. Moreover, JNKs are key players in 
neural tube closure, differentiation of nerve cells or are otherwise involved in 
the mechanisms controlling cell death. Current reports also indicate their role 
in various neurodegenerative processes including Alzheimer or Parkinson’s 
diseases, as well as some mental disorders like schizophrenia. Future normal 
brain function requires proper neuronal positioning during development. 
Cellular migration, which is a universal mechanism of development, 
promotes cell interaction by bringing cells together, in addition to movement. 
Misplacement of neurons ultimately leads to various neurological diseases, 
including epilepsy, lissencephaly and schizophrenia, but also to less severe 
disorders like dyslexia. Therefore, identification of key players involved in 
neuronal placement is crucial for future well-being. Along with various 
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modern molecular and cell biology techniques, the animal model of Jnk 
knockout mice serves as an invaluable source of information, allowing for 
better understanding of numerous pathologies. Without proper 
understanding of deep molecular processes taking place inside neurons, we 
may not be able to tackle the nature of the investigated problem correctly. 
The studies presented in this thesis shed new light on JNK1 function in the 
brain along with its interacting protein Superior Cervical Ganglion 10 
(SCG10). A better interpretation of the JNK1-SCG10 interplay will improve 
our understanding of the importance of physiologically active JNK in 
neurons.  
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REVIEW OF LITERATURE  
1.  Introduction to brain development  
1.1  Establishing cell polarity  
When considering the brain we think of electrical signals that allow 
information to pass from one cell to another. However, the very early events 
that occur during brain development take place before synapses are formed 
and are mostly free from electrical activity. Complex brain architecture is a 
result of genetic instructions, ongoing signaling between cells, and finally 
communication between the growing child and the outside world. Events 
like the formation of the primordial nervous system in the embryo, the 
appearance of newly generated neurons from undifferentiated precursors, 
the establishment of key brain regions and finally, the proper neuronal 
migration precede development of axonal pathways and formation of 
synaptic connections. Disturbance of any of those processes by genetic 
mutations, drugs, or chemical abuse may lead to dramatic consequences 
(reviewed by Purves et al., 2008).  
In vertebrates the initial distinction of nervous system appears in parallel 
with the formation of basic body axes. During a process called gastrulation, 
the endoderm, mesoderm and ectoderm that form the primitive germ layers 
are developing and being arranged. The ectoderm that forms the most outer 
layer gives rise to the nervous system, but also the skin and other external 
tissues (Solnica-Krezel, 2005).  
Shortly after the neural tube is formed, four major brain areas become 
outlined: the prosencephalon, mesencephalon, rhombencephalon as well as 
the future spinal cord, which originates from the most posterior part of the 
neural tube. Once the first brain regions are formed they undergo further 
partitioning giving rise to future adult brain structures, which is briefly 
depicted in Figure 1.  
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Figure 1. A longitudinal section of the neural tube development. At first, the neural 
tube segments into three areas: prosencephalon (forebrain), mesencephalon  
(midbrain) and rhombencephalon (hindbrain). The future spinal cord originates from 
the more posterior part of the neural tube. Further on, the prosencephalon gives rise 
to telencephalon and diencephalon, which will form the cortex, white matter, basal 
nuclei as well as the thalamus and hypothalamus.  The rhombencephalon subdivides 
into the metencephalon and myelencephalon. Those regions will form pons, 
cerebellum and medulla oblongata in the adult brain. (Modified from Purves et al., 
2008) 
The gross number of neurons is produced between weeks 12 and 18 of 
gestation with a speed of about 100 000 neurons per second (Linderkamp et 
al., 2009). That, in turn, means that there are at least 200 billion cells in the 
whole brain and 40 billion solely in the newly forming cortex. Roughly 50% 
of newborn neurons will be eliminated throughout the maturation process 
leading to a final amount of 100 billion at birth. This number represents 
roughly 100 trillion interneuronal connections (Linderkamp et al., 2009).  
The majority of neocortical pyramidal neurons are generated from radial 
glia and intermediate progenitors (IPs) between E11-E17 in murine brain and 
week 12 to 18 of gestation in human, which refers to a neurogenic phase 
(Table 1) (Noctor et al., 2004). The neurogenic phase is followed by gliogenic 
phase when astrocytes and oligodendrocytes, in the ventral region are born 
(Hirabayashi and Gotoh, 2005).  
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Table 1. Fetal cortical development: human versus mouse  
  Peak incidence Major developmental stages  
HUMAN  
  
MOUSE  
5-9 wk  
  
E8.5-E10  
1.  
2.  
Neural tube formation  
Development of prosencephalon 
(forebrain)  
HUMAN  
  
MOUSE  
12-18wk  
  
E11-E17  
1.  Neurogenesis  
HUMAN  
  
MOUSE  
12-20wk  
  
E11-E17  
1.  
2.  
Neuronal migration   
Establishment of cell layers  
HUMAN  
  
MOUSE  
22-34wk  
  
E17.5-E19  
1. 
2.  
Ultimate migration of neurons 
Regulation of axon formation between 
thalamus, cortex and subcortical 
structures  
HUMAN  
  
MOUSE  
24wk to 10mo  
  
E14- P30  
1.  
2.  
  
Extension of axons and dendrites  
Synaptogenesis  
HUMAN  
  
MOUSE  
35 wk to 24mo  
  
P10-P60 mostly  
         1.    Myelination  
Abbreviations: wk- weeks of gestation, mo- months, E- embryonic day  
Adapted from Linderkamp et al., 2009    
The key to the generation of such a complex, yet extremely well orchestrated 
structure as the brain is provided by the ability of neuronal cells to polarize 
(Yoshimura et al., 2006). During development, neurons undergo dramatic 
morphological changes. Over 20 years ago, Craig and Banker provided a model 
for studying neuronal polarity in vitro. This model is based on cultured 
pyramidal neurons extracted from rodent hippocampus. Based on the detected 
alterations in cell shape these changes have been classified into 5 stages (Dotti et 
al., 1988). The process of neuronal polarization is briefly depicted in Figure 2. 
Initially (stage 1), freshly plated cells form short protrusions known as 
lamellipodia. These extensions further evolve into short immature neurites. 
This is recognized as stage 2. Interestingly, at this point the cells remain 
unpolarized. This phase is characterized by alternating periods of elongation 
and retraction of the neurites, which leads to an even length of protrusions. In 
stage 3, this highly dynamic period ends and one of the extensions initiates 
rapid and uninterrupted growth, later on acquiring axonal morphology. In 
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stage 4 the remaining neurites slowly elongate and acquire dendritic 
characteristics. Finally, in the fifth stage cells form a neuronal network and 
establish synaptic specializations (Yoshimura et al., 2006, Cáceres et al., 2012).   
 
Figure 2. Polarization of cortical neurons in vitro versus in vivo. Freshly dissociated 
cultured neurons are present with many lamellipodial and filopodial protrusions 
(stage 1/DIV0). Next, protrusions progress into multiple immature neurites (stage 
2/DIV 1-2). During stage 3/DIV 2-4, a single neurite acquires axonal morphology 
while others form dendrites. During stage 4/DIV 4-15, both axon and dendrites 
extend in length. At the last stage 5/DIV 15-25, cells are fully differentiated with 
dendritic spines and axon initial segment (AIS). Corresponding in vivo polarization 
stages are marked in the bottom panel. E11/17 embryonic day 11/17, P21, postnatal 
day 21. Brain layers are marked as follows ventricular zone (VZ), subventricular 
zone (SVZ), intermediate zone (IZ), cortical plate (CP). At P21 six distinctive layers 
are present in CP. These are labelled: 1, 2/3, 4, 5 and 6 starting from the most 
superficial (1) to the deepest layer (6) (Modified from (Polleux and Snider, 2010). 
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Creation of the first neurite has major repercussions: it gives the neurite a 
chance to enter into axon-like growth and outlines the place of origin for the 
second one. In practice, it reflects the first stage in bipolar organization, 
which is a crucial step for neuronal migration and final brain arrangement 
(Barnes and Polleux, 2009).  
1.2  Reaching destiny: from a progenitor to a migrating cell  
Cell migration is a key process in the life of nearly all organisms. It has a 
pivotal role during embryogenesis, but in adulthood it is also essential for 
tissue repair and immune response. Understanding the mechanisms behind 
initiation, preservation and finally, termination of migration is essential for 
obtaining knowledge about how alterations in those processes may be 
contributing to neurodevelopmental disorders. Early on during murine 
cortical development precursor cells of the pseudostratified ventricular 
epithelium (PVE) span the entire depth of the neural tube wall (Del Bene et 
al., 2008). At that point they present characteristics of regular epithelia that 
are highly polarized along their apical-basal membrane (Huttner and Brand, 
1997, Chenn et al., 1998, Wodarz and Huttner, 2003). However, when 
neurogenesis starts some of the epithelial features like tight junctions or 
distribution of certain proteins associated with plasma membrane along the 
apical-basal axis become downregulated (Aaku-Saraste et al., 1997). The 
onset of the period of neurogenesis is followed by the emergence of radial 
glia and basal progenitors (Huttner and Brand, 1997, Götz, 2003, Noctor et 
al., 2004). The latter give rise to subventricular zone and during symmetrical 
cell division produce two neuronal daughter cells (Haubensak et al., 2004, 
Noctor et al., 2004). Interestingly, radial glia displays both neuroepithelial 
and astroglial properties. As a consequence most neurons in the brain 
originate from radial glia precursors, which are more fate-restricted 
progenitors than neuroepithelium (Williams and Price, 1995, Malatesta et al., 
2000). Prior to cell division neuroepithelial cells undergo interkinetic nuclear 
migration (INM). This process, initially observed by Sauer in 1935, involves 
oscillatory movement of the nucleus along the advancing cell cycle (Del Bene, 
2011). During S-phase the nucleus of the neuroepitheilum moves toward the 
basal side of ventricular zone, yet mitosis occurs only at the apical side close 
to ventricular surface (Caviness and Takahashi, 1995, Kosodo et al., 2011). 
Interestingly, in radial glia, INM is restricted to most ventricular part of the 
cell, unlike in the neuroepithelium where it stretches along the whole apical-
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basal axis. At the same time basal progenitors show hardly any INM 
(Takahashi et al., 1993, Haubensak et al., 2004). Disruption of INM may result 
in reduction of neuronal precursors therefore leading to uneven 
determination of cell fate (Schenk et al., 2009).  
When cell division is completed the newborn neurons are obliged to leave 
the ventricular zone and move to their final destinations. The distance that 
neurons must complete to reach their endpoint varies from 50-100 μm in the 
developing retina to approximately 2 cm in the cerebral cortex during radial 
migration. This length increases even more in the case of tangentially 
migrating neurons (Tsai and Gleeson, 2005, de Anda et al., 2010).  
The neocortex is composed of 6 layers (I-VI) each of which contains a 
unique subdivision of neurons that are both functionally, as well as cyto-
architecturally discrete (Bradke and Dotti, 1997, Kwan et al., 2012). The first 
cohort of postmitotic neurons leaves the ventricular zone (VZ) at E11 form 
the primordial plexiform layer, known also as the preplate (PP) right beneath 
the pial surface (Hatten, 1999, Nadarajah and Parnavelas, 2002). When the 
preplate is formed, the space between the PP and VZ is filled with newly 
forming axons and gives rise to the intermediate zone (IZ). This region will 
make up the white matter of the brain containing both afferent and efferent 
axons. The next wave of neurons migrates through the IZ and splits the PP 
into the marginal zone (MZ) and the subplate (SP) (Uylings, 2000). Cells 
located in the marginal zone will later differentiate into Cajal-Retzius cells 
and form layer I. These cells are the earliest born cells of the cerebral cortex 
and further layers II-VI are generated in an “inside out” manner within the 
cortical plate. The “inside out” term describes the phenomena where early 
born neurons occupy the deepest layers (eg. VI), while more recently born 
cells move across previously formed layers and set a new one (Rakic, 1972, 
Hatten, 1999, Nadarajah and Parnavelas, 2002).  
To date, three modes of neuronal migration have been described in the 
literature: radial, tangential and multipolar. During migration, cells undergo 
morphological changes and the bipolar shape is typically an attribute of 
radially migrating neurons, where the leading and trailing processes are in 
opposition to each other. Interestingly neurons undergoing tangential 
migration (vertical to radial glia) present great diversity in morphology.  
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1.2.1  Radial migration 
In the telencephalon region radial glia-based migration is the primary 
mechanism utilized by pyramidal neurons reaching their final positions in the 
developing brain (Angevine and Sidman, 1961, Rakic, 1974, Nadarajah et al., 
2001). Neurons move perpendicular to the VZ gliding on radial fibers hence 
increasing thickness of the cortical plate (Marín et al., 2010). It is estimated that 
80-90% of the precursors in the cortex once committed to neuronal fate move 
along the radial glia “backbone” (Anton et al., 1996). Bipolar oriented 
pyramidal neurons utilize two modes of migration known as locomotion and 
somal translocation (Nadarajah and Parnavelas, 2002). Importantly, the latter 
one is believed to be the major mode of migration during the first days of 
neuronal relocation (Nadarajah et al., 2003). Cells utilizing somal translocation 
are characterized by rather long processes stably connecting them either to the 
pial surface or to the marginal zone. In fact the length of the leading neurite 
spans the thickness of the growing cortical plate (Nadarajah et al., 2001, 
Kriegstein and Noctor, 2004). Interestingly, when radial migration is over, glial 
cells evolve into stellate astrocytes (Schmechel and Rakic, 1979, Culican et al., 
1990). The leading processes of locomoting neurons are rather short in 
comparison to translocating cells. Extension of the leading process is followed 
by nucleokinesis and eventually elimination of the trailing process (Marín et 
al., 2010). Cells undergoing translocation present an uninterrupted, smooth 
forward movement, while neurons gliding on radial glia display a 
characteristic saltatory forward movement. This in turn leads to significant 
speed differences between translocating and locomoting cells (Nadarajah et al., 
2001). Importantly, individual cells are not restricted to one mode of migration 
(Kriegstein and Noctor, 2004).  
The nucleus is undoubtedly the largest cargo in neurons and moving it 
during migration requires remodeling of the cytoskeleton (Tsai and Gleeson, 
2005). Prior to nucleokinesis the main cellular structures like the centrosome, 
microtubule organizing center (MTOC), Golgi apparatus (GA), endoplasmic 
reticulum (ER) or the mitochondria gather in front of the nucleus (Bellion et 
al., 2005). Nucleokinesis itself is critically dependent on the microtubule (MT) 
network (Lambert de Rouvroit and Goffinet, 2001), which forms a cage or a 
fork-like structure around the nucleus (Rivas and Hatten, 1995, Xie et al., 
2003). The slow move of the centrosome into the leading process is followed 
by the nucleus (Solecki et al., 2004). Proper connection between centrosome 
and nucleus seems to be one of the critical elements in neuronal migration. 
There are many recognized mutations that may negatively influence 
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migration thus leading to severe developmental consequences. Selected 
syndromes present in humans are listed in Table 2 below.  
Table 2. Mutations affecting neuronal migration in humans 
Syndrome Gene affected Description Reference 
Miller-Dieker 
syndrome  
14-3-3ε  A group of conditions which present 
failure in forebrain migration, fewer 
and smoother gyri. Characterised by 
deletion in PAFAH1B1 (platelet 
activating factor acetyldehydrogenase).
(Toyo-oka et 
al., 2003, 
Yingling et 
al., 2003)  
Lissencephaly  LIS1, TUBA1A Characterized by smooth brain. (Pilz et al., 
1998, Kumar  
et al., 2010)  
X-Linked 
lissencephaly  
Doublecortin  Females present with double cortex, due 
to mutation in doublecortin protein. 
Males suffer from lissencephaly.
(des Portes et 
al., 1998 Ross 
et al., 1997) 
Zellweger 
syndrome  
12 genes 
involved/ PEX1 
mutation 
found in 70% 
cases  
Impairment of cortical migration due to 
disturbance in peroxisomal biogenesis. 
Decreased number of gyri that are 
atypically large (stereotypic medial 
pachygyria) and present additional 
small gyri (lateral polymicrogyria).
(Baes et al., 
1997)  
Bilateral 
periventricular 
nodular band 
heterotopias  
BPNH  Neurons in the forebrain form 
heterotopias. 
(Dobyns et 
al., 1997, Fink 
et al., 1997a)  
Microencephaly ND  Though the lamination pattern seems 
to be unimpaired the observed 
thickness of the layers is reduced. 
(McKusick, 
1994)  
Schizophrenia  DISC-1  Disturbance in intracellular transport, 
neurite architecture and migration 
observed in DISC-1 protein truncation 
may add on to ontogenesis of 
schizophrenia.    
(Morris et al.  
2003)  
Fukuyama- type 
congenital 
muscular 
dustrophy  
FUKUTIN  CNS migration disturbances that 
result in changes consistent with 
cobblestone (previously type II) 
lissencephaly with cerebral and 
cerebellar cortical dysplasia. 
(Saito et al., 
2003)  
Muscle-eye- brain 
disease (MEB)  
POMGnT1  An autosomal recessive disorder 
characterized by congenital muscular 
dystrophy, ocular abnormalities, and 
lissencephaly. 
(Yoshida et  
al., 2001)  
Periventricular 
heterotopia (PH)  
Filamin A  PH is an X-linked dominant human 
disorder where many neurons fail to 
migrate and persist as nodules lining the 
ventricular surface. Females with PH 
present with epilepsy and patent ductus 
arteriosus and coagulopathy, while 
hemizygous males die embryonically. 
(Fox et al., 
1998)  
Modified from Hatten et al., 1999  
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1.2.2  Tangential migration  
In contrast to radial migration, tangential migration does not require 
communication with radial glia. Interestingly, these cells have been shown to 
be in close association with corticofugal axons, serving as a guide to the 
cortex (Métin and Godement, 1996, Denaxa et al., 2005). Tangentially moving 
neurons can migrate as a group of cells e.g. olfactory bulb interneurons, or 
individually like cortical interneurons or Cajal-Retzius cells (Marín et al., 
2010). The process of tangential migration predominantly refers to GABA 
(gammaaminobutyric acid)-containing interneurons (Anderson et al., 1997) 
with an exception of the very first cortical neurons. These neurons reach the 
cortical primordium by tangential migration however they lack the 
phenotype of an interneuron (Bystron et al., 2006). It also applies to the 
population of oligodendrocytes generated in the subpallial telencephalon 
(Spassky et al., 1998, Olivier et al., 2001). Apart from neurons traveling from 
the subpallial telencephalon to the cortex, other routes of tangential 
migration have also been observed. One such example is provided by 
progenitor cells localized to subventricular zone in telencephalon, which 
generate two types of cells in the olfactory bulb. The granule and 
periglomerular cells of olfactory bulb are GABA interneurons and move 
along the rostral migratory stream (RMS) to their destination in the olfactory 
bulb (Luskin, 1993, Lois and Alvarez-Buylla, 1994). The process of tangential 
migration to the olfactory bulb continues until adulthood (Curtis et al., 2007). 
However, neurons that are predestined for the cortex derive from distinct 
proliferative regions like the lateral ganglionic eminence (LGE), medial 
ganglionic eminence (MGE) anterior entopeduncular area (AEP) as well as 
the retrobulbar area of the olfactory bulb (Anderson et al., 2001, Cobos et al., 
2001, Wichterle et al., 2001). MGE and AEP serve as the primary source of 
tangentially migrating neurons throughout initial days of migration (E11.5 in 
the mouse). Those neurons move mainly towards the striatum, marginal 
zone and subplate in the cortex (Lavdas et al., 1999, Anderson et al., 2001). At 
later developmental stages (E12.5-E14.5), MGE serves as the primary 
reservoir of tangentially moving interneurons. Interestingly, interneurons 
derived concurrently from the LGE migrate to the olfactory bulb but not to 
the cortex (Wichterle et al., 2001). Nevertheless at a late stage (E14.5-E16.5) 
both eminences provide interneurons to the developing telencephalon 
(Anderson et al., 2001). At the beginning of neurogenesis, early-generated 
interneurons maneuver through the IZ of the eminences, yet later on they 
migrate through the VZ and SVS in order to invade the cortex. Importantly, 
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interneurons that adopt their final position in the cortex can switch from 
tangential to radial mode of migration (Polleux et al., 2002, Tanaka et al., 
2003).  
1.2.3  Multipolar migration 
The molecular mechanism underlying multipolar migration has lately come 
to the attention of the scientific community (Tabata et al., 2009, Pacary et al., 
2011). Multipolar neurons present in the SVZ and IZ come from radial glia 
precursors, similarly to bipolar pyramidal neurons (Noctor et al., 2002, 
Tabata and Nakajima, 2003). During this stage, the centrosome is localized at 
the base of an axon (Kupijers and Hoogenraad, 2011). During radial 
migration neurons move towards the pial surface. In multipolar migration 
they frequently change the direction and rate of movement, or else 
transiently remain in approximately same localization (Tabata and Nakajima, 
2003). These changes take place right before neurons start to take up a bipolar 
morphology and move in direction of the pial surface (LoTurco and Bai, 
2006). Interestingly, this transient state applies also to tangentially moving 
interneurons in the vicinity of the cortical SVZ (Nadarajah et al., 2002) and 
neurons in auditory nuclei of the brainstem (Book and Morest, 1990). In 
terms of speed, this mode of movement is the slowest among all previously 
described and reaches only 1-6 μm/h (Tabata and Nakajima, 2003). During 
bipolar migration, and in particular throughout periods of locomotion, cells 
move at approximately 10 μm/h. However, during somal translocation, cells 
travel at the speed of 10-50 μm/h towards the pial surface (Nadarajah et al., 
2001).  
The improper transition from multi- to bipolar neurons leads to altered 
migration pattern, which is depicted in Figure 3. Several independent studies 
have pointed towards Filamin A (Flna), LIS1 and DCX as molecules involved 
in the transition from the multi to the bipolar phenotype (Nadarajah et al., 
2001, Nagano et al., 2002, Bai et al., 2003, Nagano et al., 2004, Hatten, 2005).   
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Figure 3. Multipolar migration is a critical step in neuronal movement. Disruption  
in various proteins including Filamin A, LIS1, DCX or JNK1 disrupts the normal  
migration pattern and may lead to severe neurological issues in the long-term  
perspective. In Filamin A, mutant multipolar neurons fail to exit from the multipolar  
stage and remain in VZ/SVZ. Similarly LIS1 RNAi treated neurons are retained in the  
VZ/SVZ region. DCX-silent cells remain in IZ zone, whereas Jnk1-/- neurons exit  
multipolar stage faster than wt and acquire bipolar morphology (Modified from  
(LoTurco and Bai, 2006)  
 Recently JNK1 and SCG10 have been shown to be key players in this 
process, which will be further discussed in results section of this thesis 
(Study II). Manipulating the function of Filamin A and DCX with either a 
RNAi approach or protein overexpression revealed that both proteins affect 
the amount of cells in the multipolar stage (Bai et al., 2003, Nagano et al., 
2004). Likewise, LIS 1 is needed for exit from the multipolar stage since LIS1 
RNAi-treated cells remain in the VZ and SVZ without commencing to 
bipolar morphology (Hatten, 2005, Tsai et al., 2005). Moreover, at the 
transcriptional level several factors have been appointed roles in each step of 
neurogenesis including a multipolar to bipolar shift. Recently, RP58, a 
transcriptional repressor that is highly enriched in the immature brain, has 
been shown to regulate the transition from a multi to a bipolar neuron. 
Moreover it was proposed by the authors that RP58 plays a valuable role in 
neuronal migration via repression of Ngn2 and Rnd2 pathway (Ohtaka-
Maruyama et al., 2013).   
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2. The Golgi apparatus  
Over 100 years ago Camillo Golgi found a new intriguing compartment in 
spinal ganglion cells, which he described as “the internal reticular 
apparatus”. Today it is known by the name of its founder as the Golgi 
apparatus (GA). Observed in the most eukaryotic cells the GA is definitely a 
unique subcellular organelle that functions as a hub in the complex secretory 
pathway. The key features of the GA are summarized in Table 3 (Klute et al., 
2011). 
Table 3.  
Summary of Golgi complex key features 
• It functions as a hub of the secretory pathway and remains in close contact 
with the ER  
• It is built from flattened, interconnected stacks of cisternae which form a 
ribbon-like structure  
• Its structure is due to interactions with a unique cytoplasmic matrix  
• It possesses enzymes that are in charge of post-translational modifications 
of newly synthesized proteins and lipids  
• Contains additional enzymes required for sphingo- and glycolipids 
synthesis  
• GA-processing enzymes are in a continuous flow between GA, ER, plasma 
membrane and endosomes  
• Processed cargo is sorted for its destination at the trans Golgi compartment  
• “Endosomal- lysosomal” pathway is used for molecules recycled from 
plasma membrane to GA complex  
• It interacts with various components of the cytoskeleton: MTs, actin 
filaments and IFs  
• Forms a platform for a large number of signaling cascades, which, in turn 
control GA function  
• In the absence of cytoskeletal support (MTs) GA complex fragments into 
Golgi ministacks 
  
  
In contrast to the fruit fly D.melanogaster, plants and fungi where GA 
stacks are spread throughout the cytoplasm, in vertebrates the stacks are 
connected creating a ribbon-like structure in the vicinity of the nucleus 
(Xiang and Wang, 2011). In spite of its defined organization, it is a very 
dynamic structure that goes through the rapid cycles of dismantling and 
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rebuilding during the course of the advancing cell cycle, as well as upon 
various chemical treatments and finally it fragments during apoptosis 
(Machamer, 2003).    
Proteins and lipids newly synthesized in the endoplasmic reticulum (ER) 
are transported to the GA complex where various posttranslational 
modifications including phosphorylation, acylation, glycosylation, 
methylation and sulphation take place (Marsh and Howell, 2002). Then the 
final product is sent away to its destination. However, the GA recovers some 
of the proteins and lipids and sends them back to the ER, showing that the 
GA not only functions as a processing terminal but also as a screening system 
by which plasma membrane components are separated from those intended 
to remain in the ER (Mellman and Simons, 1992). Since the transport 
intermediates operating in biosynthetic-secretory trafficking may move 
across lengthy distances in cells such as neurons, it is widely acknowledged 
that the cytoskeleton is closely associated with the GA stacks (Donaldson and 
Lippincott-Schwartz, 2000).  
In mammals, GA stacks are separated from endoplasmic reticulum exit 
sites (ERES) and are in close connection with the MTOC/centrosome (Saraste 
and Goud, 2007). Close association of the GA and microtubules is 
maintained, even when the cytoskeleton is undergoing major architectural 
changes, for instance upon migration events or during neuronal polarization 
(Kupfer et al., 1982, de Anda et al., 2005). In fact, MTs tightly accompany the 
cis-GA cisterna. In addition, the GA structure is preserved by MTs 
intersecting the tubules in noncompact areas and openings in the GA ribbon 
(Marsh et al., 2001). Moreover microtubules in the close vicinity of the GA 
contain detyrosinated and acetylated tubulin, which is a feature of stable 
MTs (Schulze et al., 1987, Burgess et al., 1991). However, the 
antimicrotubular drugs lead to microtubule depolymerisation, fragmentation 
of the system of interconnected GA stacks and fragments dispersal (Thyberg 
and Moskalewski, 1999). Interestingly, the GA stacks are not randomly 
dispersed in the cytoplasm but they get redistributed close to the ER exit sites 
instead (Cole, et al., 1996, Thyberg and Moskalewski, 1999) 
2.1  Protein transport through the Golgi stacks  
The cisternal stacks of GA are often compared with a pile of pancakes. Yet it 
is worth remembering that this is an oversimplification and does explain the 
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diversity of morphologies visible in a variety of cell types (Connerly, 2010). 
Cargo proteins travelling across GA subcompartments are altered by resident 
enzymes. Consequently, they receive sugars, sulfates or phosphate groups. 
Defects in those processes may result in inborn glycosylation disorders, 
muscular dystrophy or otherwise may be a significant factor in the 
development of diabetes or cancer (Ungar, 2009). To date two main models 
have been suggested in order to explain protein flow across GA.  
The initial model proposed by Palade and colleagues in the 1960s was 
called the vesicular transport model. According to it, GA membranes are 
steady structures across which flow the cargo proteins. The vesicles that 
travel from the ER fuse with the cis-side of the GA providing newly 
synthesized proteins for further modifications. Enzymes that are meant to 
serve at the GA, remain in the stack unlike other secretory proteins that are 
packed in vesicles meant for the following cisternae. Once they reach the 
trans-side, the cargo is packed into diverse vesicles that will deliver them to 
their final destination. Importantly, structural elements like SNAP receptor 
proteins (SNAREs) or alleged cargo receptors that participate in ER-GA route 
are packed up into vesicles and send back to ER (Farquhar and Palade, 1998). 
The other model, named as cisternal maturation, proposes that vesicles 
originating in the ER contain all elements required for forming a brand new 
cis-Golgi cisterna. During the maturation process of the de novo created 
cisterna, various proteins and lipids are exchanged while they move from the 
ER to the GA and across the other GA stacks. Upon reaching the trans-face, 
the cisterna collapses and GA components are recycled.  Cargoes are then 
enclosed in carrier vesicles that will ensure their delivery to their final 
destinations (Rothman and Wieland, 1996, Pelham, 1998). The following 
models are briefly depicted in Figure 4.   
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Figure 4. Transport of cargo across Golgi stacks; vesicular transport versus 
cisternal maturation model. In the vesicular transport model the ER-derived vesicle 
fuses with cis-Golgi and delivers the cargo. While the cargo undergoes various 
posttranslational modifications, ER-escaped proteins, SNAREs or other transport 
involved ER to GA components are packed into vesicles and travel back to ER. Upon 
reaching the trans-face the cargo is redistributed into appropriate vesicle for its 
destiny. In the cisternal maturation model the ER derived “new” Golgi cis-
compartment matures by exchanging enzymes and lipids but not the cargo. Proteins 
are transported within cisternae, while vesicles take back resident proteins in a 
retrograde way. (Modified from Short and Barr, 2000).   
The organization of GA membranes still remains to be addressed. 
Nevertheless, several factors affect Golgi membranes, including coat complex 
proteins I (COPI), conserved oligomeric Golgi (COG) tethering complexes, 
Rab GTPases, SNAREs, long coiled-coil tethering factors. The latter from the 
“golgin family” (Miaczynska and Zerial, 2002, Rein et al., 2002, Barr and 
Short, 2003, Duden, 2003, Ungar and Hughson, 2003, Marquardt, 2004). The 
family of golgins has also been linked to proper GA function. It has been 
shown that various members of the family play a role in cisternal stacking 
and tethering of vesicles, as well as acting as effectors of various Rab proteins 
(Gleeson et al., 1996, Short et al., 2001). Several golgins including giantin, 
golgin-230, GMAP210 or GM130 regulate the structure of the GA (Nakamura 
et al., 1997).  
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2.2  The Golgi apparatus as a crossroad of cellular trafficking 
Eukaryotic cells are extraordinary structures able to respond to both extra- and 
intracellular ques. Beginning at the plasma membrane, which is rich in various 
receptors, they can transfer the incoming signal to different proteins present in 
the cytoplasm. This in turn triggers further partners of the signaling cascade 
triggering a final cellular response. It has been estimated that around 10-12% of 
human genes encode for proteins involved in signal transduction (Imanishi et 
al., 2004). GA membranes accommodate a great number of signaling particles 
including a variety of kinases, phosphatases, phospholipases, heterotrimeric 
G-proteins and phosphodiestrases (Mazzoni et al., 1992, Polizotto et al., 1999). 
Many of the regulatory proteins present at the GA have been shown to 
regulate its function. They can also alter the signaling lipids present in the GA 
membrane as well as manage its contact with the surrounding cytoskeleton 
(De Matteis and Morrow, 1998, Godi et al., 1999).   
A recent RNAi screen revealed that eight members of the MAP kinase 
family and thirteen closely related genes were found to control GA function 
in human cells (Chia et al., 2012). It was previously shown that active ERK, 
H-ras as well as MEK are present at the GA (Torii et al., 2004). ERK can 
phosphorylate GA reassembly stacking protein (GRASP65) at Ser227 during 
interphase leading to the disassembly of the stacks (Yoshimura et al., 2005, 
Wei and Seemann, 2009). In 2003, Harada and co-workers found that Akr1p-
like 1 and 2 (AKRL 1 and AKRL 2), both present at the Golgi, are potent 
activators of JNK. Moreover direct JNK activators MKK4 and MKK7 were 
also activated in the presence of AKRL1/2. In addition, DLK/MUK/ZPK 
known JNK activator was found on the periphery of GA in NIH 3T3 cells 
(Holzman et al., 1994, Douziech et al., 1999).  
2.3  The role of the Golgi apparatus in health and disease 
Over the years it has been observed that the GA may fragment under specific 
conditions. Those can be stimulated by physiological responses or conversely 
by pathological conditions (Gonatas et al., 2006). During mitosis GA stacks 
are known to disassemble and are equally divided between the two daughter 
cells. After the mitotic program is finished, the GA, together with the nuclear 
envelope, is re-building. Additionally, blocking GA disassembly inhibits cell 
entrance into mitosis (Sütterlin et al., 2002). A variety of kinases have been 
linked to promoting GA fragmentation during mitosis by phosphorylation of 
  
30
a variety of GA proteins. Among those are Cdc2, RAF/MEK1/ERK1c, Plk1, 
Plk3 and Cdk5 (Acharya et al., 1998, Sütterlin et al., 2001, Xie et al., 2004a, 
Sun et al., 2008). Interestingly, it was also observed that during apoptosis GA 
membranes fragment into smaller tubulovesicular clusters, resembling those 
previously noted upon mitotic disassembly (Chiu et al., 2002, Lane et al., 
2002, Machamer, 2003). Several structural proteins are cleaved in a caspase-
mediated manner, and therefore apoptotic fragmentation, unlike the one 
observed during cell division, is irreversible. Golgin160, GRASP65, p115 and 
GM130 are primary targets of various caspases upon apoptotic stimuli 
(Mancini et al., 2000, Lane et al., 2002).  
For the first time, GA fragmentation was observed in vivo in a disease 
model of sporadic amyotrophic lateral sclerosis. Although affected spinal cord 
motor neurons maintained intact nuclei as well as axons and dendrites, the 
secretory pathway was compromised as shown by morphometric 
measurements (Gonatas et al., 1992, Gonatas et al., 2006). Similar lesions were 
also found in the familial form of ALS (fALS), which is characterized by 
mutation in superoxide dismutase (SOD1). Interestingly, in the studied mouse 
model, GA fragmentation alongside the accumulation of mutant SOD1 was 
noticed already long before the signs of paralysis appeared (Gurney et al., 
1994, Stieber et al., 2000). Several other neurodegenerative diseases involve the 
accumulation of misfolded proteins leading to impaired neuronal connectivity 
and cellular plasticity, which in turn initiates cell death (Bence et al., 2001). 
Among those are Alzheimer’s (AD), Parkinson’s (PD), corticobasal 
degeneration and Creutzfeldt-Jacob disease (Stieber et al., 1996, Sakurai et al., 
2000, Gosavi et al., 2002). Alzheimer’s and Parkinson’s diseases are the two 
most common neurodegenerative disorders among people above the age of 65 
years (Tanner and Ben-Shlomo, 1999, Gibrat et al., 2009). It was previously 
shown that accumulation of α-synuclein in cultured cells inhibits 
mitochondrial function, protein synthesis, proteasome function, exocytosis, 
and oxidative stress (Cookson and van der Brug, 2008). The study conducted 
by Cooper and collegues (Cooper et al., 2006) shed a new light on α-synuclein 
function. They found that the overexpression of α-synuclein suppressed the 
growth of yeast cells. The observed pathology was mainly due to the actions of 
α-synuclein on ER-to-Golgi vesicle transport. This however, could be rescued 
by overexpression of Rab1 (Ypt1p in yeast) protein (Cooper et al., 2006), which 
plays a key role in tethering/docking of the vesicles to GA compartments 
(Moyer et al., 2001, Cooper et al., 2006).  A later study from Jesse C. Hay group 
showed that mild overexpression of human α-synuclein in normal rat kidney 
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(NRK) cells, wild type and disease-associated mutants strongly inhibited ER-
to-Golgi transport. Upon expressions of SNAREs the transport inhibition was 
reversed without affecting α-synuclein expression, localization, aggregation or 
disposal (Thayanidhi et al., 2010).  
It has been suggested that the size of GA may correlate with neuronal 
activity. Therefore readout of its condition can be indicative of ongoing 
pathology (Stieber et al., 1996). A morphometric study on tissue from AD 
brains showed that neurons lacking neurofibrillary tangles (NFTs) presented 
with fragmented and atrophic GA. Conversely, the NTFs positive cells had 
GA mostly displaced by NFTs and the remaining GA stacks were unbalanced 
and merged into bigger aggregates (Salehi et al., 1994). Moreover, in AD, GA 
fragmentation was similar to that observed in ALS but also the one seen in 
vitro when treating cells with microtubule depolymerizing agents (Robbins 
and Gonatas, 1964, Turner and Tartakoff, 1989). Interestingly, protein 
profiling performed on spinal cord neurons from a mouse model of human 
familial ALS revealed that stathmin protein accumulated in the cytoplasm of 
neurons alongside the fragmented GA. Moreover membrane–bound SCG10 
and SCLIP accumulated in a fashion similar to stathmin in diseased cells 
(Strey et al., 2006). It was also shown that stathmin is downregulated when 
heavily phosphorylated (Strey et al., 2004). As a consequence of microtubule 
depolymerization GA stacks disassemble (Gonatas et al., 2006). This in turn 
may impair trafficking and the secretory pathway (Stieber et al., 1996, Strey 
et al., 2004).    
Nakagomi and co-workers showed that the disassembly of GA came prior 
to neuronal cell death in response to various stressors, including excitotoxic, 
oxidative/nitrosative insult or ER stress. Interestingly, overexpression of the 
C-terminal fragment of GRASP65 impeded fragmentation, consequently 
postponing cell death. Likewise, blocking of the mitochondrial or ER death 
signaling pathways reduced the extent of fragmentation (Nakagomi et al., 
2008). Until recently, it has been believed that GA fragmentation is an 
irreversible process eventually leading to cell death. A recent report suggests 
this process may be in fact reversible under special conditions. Lily Yeh Jan’s 
group performed an in vitro study on hippocampal neurons cultured in 
hyperexcitable conditions to show that transiently fragmented GA may 
revert to its native state. They found that GA disassembles in the presence of 
elevated potassium, yet this process is reversible upon its removal. 
Moreover, they also found that extended treatment with bicuculline or 
withdrawal of APV leading to increased neuronal activity, results in GA 
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fragmentation. Importantly GA stacks reorganized back to their normal state 
once neuronal activity returned to basal levels (Thayer et al., 2013). In the 
light of the previously published reports, this study sheds new light on GA 
fragmentation emphasizing that the GA breakdown is recoverable. 
Nonetheless, much work still needs to be done to unravel the exact 
mechanism of GA fragmentation.  
2.4  Neurons: specialized cells with particular demands 
Neurons are considerably bigger than non-neuronal cells. The shape and size 
dictate particular demands for neurons.  Distinctively, they rely on protein 
and organelle transport from cell body to axon and dendrites. Cellular 
polarization, as well as multifaceted morphologies, gives rise to additional 
challenges (Brady and Morfini, 2010). Nowadays, it is estimated that 
approximately 40-400 different mRNAs are employed in localized translation 
in dendrites (Eberwine et al., 2001, Steward and Schuman, 2001). This allows 
cells to respond quickly to localized signals. Nevertheless, most proteins are 
produced in the cell body and need to exit GA to reach their destination 
(Brady and Morfini, 2010).  
2.4.1  Golgi outposts 
It was shown in a non-neuronal system that microtubules might arise from 
other intracellular elements than the MTOC/centrosome. In a process 
referred to as acentrosomal nucleation, microtubules originate from varied 
sites including the nuclear envelope, melanosomes, the plasma membrane or 
the GA (Vinogradova et al., 2009). Several proteins have been listed as 
important in nucleation of microtubules. These include γ-tubulin, AKAP450, 
GM130 and CLASP (Baas and Yu, 1996, Ahmad et al., 1998, Efimov et al., 
2007, Kollman et al., 2010). In neurons whose discrete and highly complex 
architecture is maintained by a dynamic array of microtubules, the process of 
the nucleation of microtubules needs to be well maintained (Desai and 
Mitchison, 1997, Hoogenraad and Bradke, 2009). Hence, several studies have 
undertaken the challenge of investigating this process in the neuronal 
system. The requirement of centrosomes, but not γ-tubulin, is lost when 
neurons get older and MTs arise from acentrosomal sites (Stiess et al., 2010).   
Dendrites of mammalian neurons when observed in vitro present with 
mixed orientation of microtubules in the vicinity of the cell body. At the same 
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time are organized in a plus-end-out manner in more distal regions (Stepanova 
et al., 2003, Baas and Lin, 2011). Interestingly, in Drosophila melanogaster the 
array of microtubules in dendrites is highly polarized with a minus end 
situated away from the cell soma (Stone et al., 2008). Both in mammals and the 
fruit fly, dendrites can be discriminated from axons by minus-end-out 
microtubules (Nguyen et al., 2011). Importantly it was noticed in dendritic 
arborization (da) neurons in D. melanogaster that neurons grow complex 
dendritic arbors despite the absence of centrosomes (Grueber et al., 2003, 
Nguyen et al., 2011). Moreover, the centrosome serves as a primary site for 
microtubule nucleation only in young cortical neurons (DIV 2), but not in the 
mature culture (DIV 11-12), where γ-tubulin is depleted from the centrosome 
(Stiess et al., 2010). Likewise in fibroblasts it has been shown that the GA can 
serve as a site of microtubule nucleation independently of the centrosome 
(Chabin-Brion et al., 2001, Efimov et al., 2007).  Although MTs do not require 
centrosome as an initiation point for their growth they still require the 
presence of γ-tubulin, AKAP450 and CLASP proteins (Chabin-Brion et al., 
2001, Efimov et al., 2007, Miller et al., 2009).   
In neurons, regardless of the origin, mammalian or the fruit fly’s so-called 
Golgi outposts are present only in dendrites (Gardiol et al., 1999, Pierce et al., 
2001, Horton and Ehlers, 2003). The incidence pattern, however, is slightly 
different. In the fruit fly Golgi outposts are present all over dendritic arbors 
while in hippocampal neurons they localize to a group of primary branches 
(Horton et al., 2005). Similar to mammalian the Golgi outposts found in class 
IV da neurons contain all components essential to start up the process of 
microtubule nucleation (Efimov et al., 2007, Ori-McKenney et al., 2012). They 
contain γ-tubulin and Drosophila’s homolog of AKAP450, CP309 protein, both 
critical in Golgi-outposts microtubule nucleation process (Ori-McKenney et 
al., 2012). Presumably smaller outposts support dendrite branching and 
neurite outgrowth by delivering membranes. Nonetheless the bigger ones 
that are more immobile and present at dendrite branch points in 
hippocampal neurons could also serve additional functions such as regional 
protein translation (Eberwine et al., 2001, Horton et al., 2005, Ye et al., 2007). 
A recently published study by Garner and Green laboratory indicates that 
NMDA receptor trafficking engages both Golgi outposts and the dendritic 
ER subcompartment (Jeyifous et al., 2009). Interestingly, the majority of 
NMDA receptors were noted to employ Golgi outposts and this required 
assistance from COPI coated vesicles (Jeyifous et al., 2009).  
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3.  C-Jun N-Terminal Kinases (JNKs) 
3.1  MAP kinase pathways 
Mitogen activated protein kinases have been well conserved during 
evolution. They are present from yeast to humans and share a similar 
activation scheme that comprises a three-tiered signaling cascade, known as 
the core-signaling module (Karin, 1996, Kyriakis and Avruch, 2012). Such a 
cascade involves sequential phosphorylation events targeting an activation 
loop, which is a typical structural element of all protein kinases (Goldsmith 
and Cobb, 1994). Phosphate transfer to the activation loop leads to 
conformational changes, which in turn make the catalytic site available to 
ATP and potential substrates (Goldsmith et al., 2004). Protein 
phosphorylation plays a crucial role in many cellular events. It controls 
metabolism, cell division, cell movement, but also determines cell survival or 
else death. Hence, any disturbance in ordinary phosphorylation events may 
result in signaling cascade malfunction resulting in a severe disease state in 
the whole organism (Cohen and Alessi, 2013). Based on conserved motifs, 
over 500 protein kinases have been identified in the human genome to date. 
Based on similarities within sequences among recognized kinases they are 
classified into 20 families (Manning et al., 2002).  
The c-Jun N-terminal kinases belong to a larger group of serine/threonine 
(Ser/Thr) protein kinases. They are known as mitogen activated protein 
kinases (MAPK) a subgroup of CMGC protein kinase (cyclin dependent 
kinases, MAPKs, glycogen synthase kinase 3 (GSK3), and casein kinase 2-
related protein kinase) (Hanks and Quinn, 1991). The extracellular signal-
regulated kinases 1 and 2 (ERK1 and ERK2), stress and proinflammatory 
activated p38 kinase (p38 α,β,γ,δ) and JNK family of kinases are considered 
to be fundamental MAPK. All MAPKs are proline-directed, meaning that 
they target serine/threonine residues that are in the direct vicinity of a 
proline. Particular docking sites are those that further maintain high 
substrate specificity of MAP kinases, providing steady and selective interplay 
between MAP kinases and their genuine targets (Kyriakis and Avruch 2012).  
JNKs act within a protein kinase cascade consisting of MAPKKKs (MKKKs), 
MAPKKs (MKKs) and MAPKs. The simplified MAPK signaling pathway is 
depicted in Figure 5 (Kyriakis and Avruch, 2001, Johnson and Nakamura, 2007). 
MKK4 and MKK7 control JNK phosphorylation within a conserved motif Thr-
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Pro-Tyr. Both kinases show site directed specificity and MKK4 demonstrates a 
preference for Y185, whereas MKK7 targets T183 (Wada et al., 2001, Kishimoto 
et al., 2003). Importantly, MKK4 may also act via the p38 pathway.  There are at 
least 20 MAPKK kinases, among which the majority may signal via activation of 
MKK4 or MKK7. Activation of both MAPKKs (MKK4 and MKK7) is mediated 
by MEKK1-4, mixed lineage kinases (MLK), dual leucine zipper kinase (DLK), 
apoptosis signal-regulating kinases (ASKs), transforming growth factor β-
activated kinase (TAK), Cdc42 and Rac (Bogoyevitch and Kobe, 2006). JNKs are 
activated in response to mitogens. Nonetheless, they are also triggered in answer 
to a variety of environmental stress like heat shock, radiation, oxidants, ischemic 
reperfusion, mechanical shear stress, genotoxins, vasoactive peptides, and least 
but not last, cycloheximide and anisomycin (Dérijard et al., 1994, Kyriakis and 
Avruch, 2012).  
 
Figure 5. A simplified scheme of the JNK cascade. Diverse extra- and intracellular  
stimuli may activate the MAPK pathway. Among those are: UV, heat shock, 
hyperosmolarity, cytokines, interleukins, Toll-like receptors or ER stress, including 
protein misfolding. All MAPKs are controlled by direct phosphorylation by 
upstream MAP kinase kinases (MAPKKs or MAP2Ks), which are in turn 
phosphorylated by MAP kinase kinase kinases (MAPKKKs or MAP3Ks). JNK is 
activated by dual specificity MEK kinases (MKK4 and MKK7) on two sites T183 and 
Y185 within the activation domain. For the simplicity of the scheme only some 
MAPK targets are included.  
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Complexity of MAP kinase signaling provided by diversity of MAPKKK 
regulation permits responses to a huge range of diverse signals both intra- 
and extracellularly (Kyriakis and Avruch, 1990, 2012).  
3.2  JNKs family 
When originally discovered in the liver of cycloheximide-challenged rats, Jnk 
was classified as a stress-activated protein kinase (SAPKs) (Kyriakis and 
Avruch, 1990). In contrast to D. melanogaster that has only one JNK protein 
encoded by basket (bsk) (Sluss et al., 1996), the mammalian genome has three 
Jnk genes, namely Jnk1 (Mapk8), Jnk2 (Mapk9) and Jnk3 (Mapk10) (Kyriakis 
and Avruch, 2012). In human JNK genes are located to chromosomes 10, 5 
and 4 for JNK1, JNK2 and JNK3 respectively. In rodents they localize to 
chromosomes 14, 11 and 5 in mouse and chromosome 16, 10, 14 in rat 
(Haeusgen et al., 2011). While JNK1 and JNK2 can be found in a wide range 
of tissues, JNK3 is primarily expressed in the brain, heart and testis (Kuan et 
al., 1999, Manning et al., 2002). Structurally JNKs resemble any other protein 
kinase (Hanks et al., 1988). They contain two domains, and while the N-
terminal domain is mainly formed by β-structures the C-terminus is rich in 
α-helices. Although JNK has an insertion in the C-terminus typical for MAP 
kinases, this extension is 12 residues longer among JNKs than in comparison 
to ERK or p38 kinases (Bogoyevitch and Kobe, 2006). As a result of 
alternative splicing within a region across subdomain IX and X (α and β JNK 
isoforms) and their C-terminus (JNK type 1 and 2) there are 10 JNK variants 
with a size range between 46 and 54kDa (Gupta et al., 1996). Although the 
functional significance of the two JNK types (1 and 2) still remains to be 
elucidated, the α and β isoforms seem to show differences in substrate 
preferences (Dérijard et al., 1994, Kallunki et al., 1994, Dai et al., 1995). A 
wide range of intracellular substrates and the complexity of the MAPK 
signaling pathway itself often evoke apparently opposing cellular responses. 
Thus it is essential to remember that cellular response to JNK activation will 
be a combination of two seemingly independent events. One of them is a 
physiological context that leads to JNK activation and the other one is the 
time it takes for the signal to last. And so transient activation of JNK within 
1h may signal pro-survival events whereas a later phase, a continuous one 
gives rise to pro-apoptotic signaling (Ventura et al., 2006).  
  
37
3.3  JNK input into brain development 
Development of the neural tube, the precursor of the nervous system, occurs in 
two ways as a result of a primary and secondary neurulation. As soon as the 
neural plate is formed the primary process begins. This step is led by cells in the 
vicinity of the neural plate that stimulate cells of the neural plate to proliferate, 
infold and to finally form an empty tube. In the secondary neurulation neural 
tube is a result of a dense string of cells that penetrates into the growing embryo 
to mold a hollow tube. The degree to which these are used differ across 
vertebrates (Gilbert SF, 2000). In fish we deal exclusively with secondary mode of 
neurulation, while in amphibians like Xenopus, the neural tube is mostly formed 
by primary type neurulation, except in the tail where it arises from the secondary 
mode. In mammals, both types of neurulation have been observed and secondary 
form appears at the upcoming upper sacral level (Copp et al., 2003).  
Neural tube defects (NTDs) are one of the most widespread inborn anomalies 
detected. About 300 000 children are born each year with NTD globally (Kondo 
et al., 2009). Excencephaly is a condition where cranial nerve tube remains open, 
and it is characterized by an outfolded appearance (Copp et al., 1990). The 
majority of mammalian cells tightly control JNK activation and only under very 
specific circumstances is its activity triggered. Conversely, in the brain, JNK 
kinase is highly and constitutively active. This elevated activity comes from 
JNK1 mainly, whereas JNK2/3 although someway active constitutively, have 
received more attention as a stress responsive JNKs (Coffey et al., 2002). 
Knockout studies provide invaluable information on gene function. Mice devoid 
of a single Jnk gene grow and breed normally like their wild type counterparts 
(Yang et al., 1997, Yang et al., 1998, Dong et al., 2001), whereas Jnk1 and Jnk2 
double knockout mice die early during embryogenesis (E11.5) and present with 
defects in the neural tube closure (Kuan et al., 1999). Removal of both genes 
resulted in decreased apoptosis in the hindbrain, preceding the neural tube 
closure (excencephaly phenotype) and increased cell death accompanied by 
activation of caspase-3 in the forebrain (Kuan et al., 1999, Sabapathy et al., 1999). 
Although the process of neural tube closure requires cell migration no major 
defects in cell movement at this stage were observed in the double knockout 
mice. Interestingly, the number of proliferative cells also remained unchanged 
(Kuan et al., 1999, Sabapathy et al., 1999). Moreover analysis of various Jnk 
mutants revealed that Jnk1-/-; Jnk2+/- show excencephaly, however Jnk+/-; Jnk2-/- do 
not (Table 4). This suggests that the leading role of Jnk1 is in the regulation of 
neural tube closure (Sabapathy et al., 1999).   
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Later on, it was shown that in Jnk1-/- mice the establishment of the 
anterior commissure tract is disturbed and also these mice increasingly loose 
microtubules within axons and dendrites (Chang et al., 2003). Moreover, a 
single knockout of Jnk1 revealed its role in dendrite formation and axon 
maintenance at later stages of brain development (Chang et al., 2003, 
Björkblom et al., 2005). Jnk2 and Jnk3 knockout studies showed the 
importance of those in cell death-induced stress in mature brain. Jnk2-/- like 
Jnk3-/- single knockouts showed no overt brain malformations, contrary to 
Jnk1-/-. Interestingly they showed resistance to 1-methyl-4phenyl-1,2,3,6-
tetrahydropirydine (MPTP) which leads to death of dopaminergic neurons 
and reproduce symptoms of PD’s (Dauer and Przedborski, 2003, Hunot et al., 
2004). Moreover, Jnk3-/- mice present reduced cell death to kainate and 
neonates display resistance to ischemia-induced cell death (Yang et al., 1997, 
Kuan et al., 2003, Pirianov et al., 2007). Furthermore, Morishima et al., (2001) 
showed that in vitro Jnk3-/- cells are less sensitive to apoptotic death induced 
by β-amyloid in AD’s. Jnk3-/- neurons moreover showed transient resistance 
to administration of 6-hydroxydopamine that under normal conditions leads 
to death of dopaminergic neurons in substantia nigra pars compacta (Brecht et 
al., 2005). Analogous to single deficiencies of JNK, dual null mice for Jnk1-/-; 
Jnk3-/- and Jnk2-/-; Jnk3-/- develop normally. Interestingly, genetic ablation of 
any of direct Jnk activators, namely Mkk4 and Mkk7 does not phenocopy 
defects in neural tube development (Ganiatsas et al., 1998, Wada et al., 2004). 
Single knockout mice of either Mkk4 or Mkk7 die between E.11.5-E13.5 due to 
liver-related pathogenesis. Double knockout embryos, however, do not 
survive past day E8.5 (Asaoka and Nishina, 2010).  
To date, not many JNK substrates can provide further details on the role 
of JNK in brain morphogenesis. Some transcription factors, known as JNK 
targets could be of a great importance during early embryogenesis. Null mice 
for downstream Jnk targets, c-Jun or Atf2, do not share the Jnk1-/-; Jnk2-/- 
phenotype. Notably, cJun -/- mice die due to hepatic defects similarly to Mkk4 
or Mkk7 knockout mice whereas Atf2-/- animals die at birth because of 
respiratory failure (Maekawa et al., 1999, Behrens 2002). Interestingly, a novel 
Jnk substrate in the brain has been recently identified. It is a myristoylated 
Alanine Rich C-Kinase Substrate Like protein -1 (MARCKSL1) which is an 
actin regulatory protein (Björkblom et al., 2012). Disruption of MARCKSL1 
gene in mice leads to neural tube defects resembling the phenotype of Jnk1-/-; 
Jnk2-/- mice with regards to the observed excencephaly in those animals (Wu 
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et al., 1996b, Kuan et al., 1999, Björkblom et al., 2012). So far it is the only Jnk 
substrate known to cause isolated neural tube malformations.   
3.4  JNK substrate specificity 
In humans, it is predicted that each kinase has approximately 40 potential 
substrates (Johnson and Hunter, 2005). To date more than 50 JNK target 
proteins have been found and the search is not over (Kyriakis and Avruch, 
2012). Apart from the most famous, giving its name to the kinase, 
transcription factor c-Jun, the diverse JNK substrates fit in all different 
groups of proteins. Moreover they are scattered across all cellular 
compartments (Haeusgen et al., 2011). The MAPK signaling cascade permits 
cells to understand the external signals and react accordingly. Only in the cell 
nucleus there are at least 26 substrates for JNK, among which many are 
transcription factors that modify gene expression following a specific 
stimulus (Bogoyevitch and Kobe, 2006). Yet the cellular functions behind JNK 
regulation range from differentiation and proliferation to movement and 
inflammation. Thus cells have acquired novel mechanisms that allow a 
particular signaling cascade to regulate various functions in response to a 
wide array of stimuli.   
The specificity of the JNK pathway is achieved by a number of 
mechanisms that control components of MAP kinase module both 
temporally and spatially (Hibi et al., 1993, Brown and Sacks, 2009). Scaffold 
proteins are an essential element to this puzzle. By bringing together several 
components of the JNK cascade these multidomain proteins assemble into a 
signaling complex (Davis, 2000, Park et al., 2003). They allow signals to pass 
quickly within the module but also they may serve a catalytic role in some 
cases. Importantly, they isolate signaling cascades from each other hence 
reducing possible crosstalk (Whitmarsh and Davis, 1998). Scaffolding is just 
one of the mechanisms ensuring specificity to the JNK kinase cascade. 
Studies on c-Jun exposed the need of a distinct phosphorylation site sequence 
of amino acids on the substrate (Adler et al., 1994, Dérijard et al., 1994). This 
domain has been named as JNK-binding domain or δ domain (Dai et al., 
1995). It is also known as common docking domain (CD), thanks to their role 
in facilitating communication between other MAPKs and their target 
proteins, various activators and scaffolds (Tanoue et al., 2000). The presence 
of CDs in a protein greatly improves the specificity and efficiency of target 
protein phosphorylation (Sharrocks et al., 2000).  
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Although today we understand the main mechanisms behind JNK 
pathway specificity, little is still known about various JNK isoforms and their 
substrate penchants. Despite a high degree of sequence similarities among 
JNK isoforms, there seems to be a predilection for different substrates. A 
good example has been provided by Gdalyahu et al. 2004, who showed that 
it is JNK2 but not JNK1 that preferably interacts with doublecortin (DCX). 
Furthermore based on in vitro and in vivo binding assays, JNK2 and not 
JNK1, has been concluded to be the interacting partner for human ATFa  
(Bocco et al., 1996) while the E3 ligase Itch is a preferred target for JNK1 (Gao 
et al., 2004). Moreover JNK1 among all JNKs shows preference for SCG10 
phosphorylation (Tararuk et al., 2006). Therefore for future studies it seems 
of a high importance to continue the search for isoform-dependent roles of 
JNKs.   
4.  Neuronal cytoskeleton 
The cytoskeleton is one of the fundamental elements that describe a 
eukaryotic cell. In neurons it refers to three distinct yet interacting 
complexes, each of which has discrete qualities. These are microtubules 
(MTs), intermediate filaments (IFs) and microfilaments (MFs) (Kirkpartick 
and Brody, 1999). The general basic structural elements of MTs are the same 
in neuronal and non-neuronal cells. However, brain MTs create quite a 
distinct pool with a variety of tubulin isotypes (some neuron-specific eg. 
class III, IVa), post-translational tubulin modifications (PTMs) and collection 
of microtubule-associated proteins (MAPs) than is present in other cell types. 
Moreover, organization of MTs differs significantly between axons and 
dendrites in at least two aspects. For instance, MTs present in axons are 
uniformly oriented, with a plus-end directed towards the tip of the neurite, 
while in dendrites MTs show mixed orientation, having plus-end aiming at 
either the tip of the dendrite or cell body. In addition these two cellular 
compartments differ in their complement of microtubule associated proteins 
with MAP2 protein mostly present in dendrites and tau in axons (Conde and 
Caceres, 2009). Furthermore, a variety of post-translational modifications 
(PTMs) including polyglutamylation, polyglycylation, acetylation, 
phosphorylation, palmitoylation and detyronisation may affect stability of 
MTs or their structure. In addition, they also play a role in the recruitment of 
specific effectors (Hammond et al., 2008). Some PTMs like detyrosination has 
been widely used to identify a stable pool of MTs (Schulze et al., 1987).  
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The IFs are uniformly distributed across the cell body. Within this large 
protein family are the neurofilaments (NF), the primary IF subtype expressed 
in neurons (Trojanowski et al., 1986). They consist of three subunits, known 
as a NF triplet: high, medium and low molecular weight, 180 to 200 kDa, 130 
to 170 kDa and 60 to 70 kDa, respectively. Each subunit is a product of a 
separate gene (Fliegner and Liem, 1991, Lee and Cleveland, 1996). The NF 
triplet proteins are neuron specific and are classified as group IV IFs together 
with α-internexin, nestin and synemin. Other brain-related IFs belong to class 
III, including vimentin, GFAP and peripherin. The NF triplet proteins keep 
the central core domain of 40kDa, which structurally is a characteristic 
element of all IFs (Lewis and Cowan, 1985). Furthermore, they can be few 
hundreds micrometers in length. Although they look as ropelike fibers 
similarly to other IFs, they have a distinct side arm protruding from the 
surface. The projecting arm is a small 10kDa amino-terminal domain on one 
side and a carboxy tail domain on the other (Fliegner and Liem, 1991). In 
neurons IFs are important elements determining axonal caliber. This is 
particularly significant in large fibers (Lee and Cleveland, 1996).   
Microfilaments are made of actin and resemble a string of pearls when 
two threads of actin get twisted around each other (Theriot, 1994). 
Microfilaments are found everywhere in neurons and glia, however they 
tend to concentrate at particular regions inside the cell. These are plasma 
membrane, presynaptic terminals, dendritic spines as well as growth cones 
(Hitt and Luna, 1994). Actin filaments are yet another set of highly dynamic 
elements of the neuronal cytoskeleton undergoing cycles of continuous 
polymerization and disassembly. The switch between G-actin (monomeric 
form) and F-actin (filamentous form) is regulated by the hydrolysis of ATP. 
Similarly to microtubules, F-actin polymers exhibit structural polarity with a 
minus (pointed) end at one side and plus (barbed) end at the other. The 
barbed end is known for its dynamic growth due to addition of G-actin-ATP 
bound monomers while ADP-bound monomers dissociate from the  
pointed end. The actin filament treadmilling process of continuous 
polymerization/depolymerisation is utilized in a variety of cellular processes 
including motility, adhesion, endocytosis and in regulation of cell 
morphology (Pollard and Borisy, 2003).   
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4.1  From simple tubulin dimers to complex filamentous structures 
Microtubules consist of α/β tubulin heterodimers that joined end to end with 
alternating α and β subunits form a protofilament. These laterally associated 
building blocks form hollow cylinders about 25 nm wide. Protofilaments are 
bound to each other via noncovalent interactions (Desai and Mitchison, 
1997). To serve their role microtubules need to be correctly nucleated. It was 
thought that this only takes place at the region of the centrosome where 
centrioles together with pericentriolar material create a microtubule friendly 
environment (Mandelkow and Mandelkow, 1995, Pereira and Schiebel, 1997). 
However, it came into attention that in some cells, like A498 kidney cell lines 
or retinal pigment epithelial cells, the process of nucleation can be 
centrosome independent (Yvon and Wadsworth, 1997, Efimov et al., 2007). 
As previously mentioned, Golgi outposts may serve as microtubule 
nucleation centers (Ori-McKenney et al., 2012). Moreover, during the 
development of hippocampal neurons the centrosome is no longer needed 
for nucleation, as neurites continue to expand even after laser ablation of the 
centrosome (Stiess et al., 2010). One of the key players in the process of 
nucleation is γ-tubulin which, when recruited, leads to microtubule assembly 
at their minus end (Raff et al., 1993, Zheng et al., 1995).  
Microtubules present distinctive polarity, which reflects their role in a 
variety of cellular processes. Due to the arrangement of α/β tubulin 
heterodimers within the microtubule, one end of the cylinder always has α-
tubulin exposed (minus end) whereas the other end, referred to as plus end, 
always has β uncovered.  Present in all eukaryotic cells, these dynamic 
polymers take part in cell division or intracellular transport. In addition they 
maintain cell shape and are involved in cell motility (Steinmetz, 2007).   
The fundamental feature of microtubules is their dynamic instability at the 
plus growing end (Desai and Mitchison, 1997). The concept of dynamic 
instability depicts a constant change between depolymerization/shrinkage 
and polymerization/growing phase. This process is tightly controlled by an 
internal equilibrium between stabilizing and destabilizing factors (Desai and 
Mitchison, 1997). Each α and β subunit of tubulin is bound to guanosine 
triphosphate (GTP). The GTP attached to a α subunit is neither hydrolysable 
nor exchangeable. Importantly, the GTP bound to a β subunit is both 
exchangeable, when the dimers are unassembled, and hydrolysable (Wang et 
al., 2007). Formation of MTs involves hydrolysis of β-bound GTP to GDP and 
Pi, yet it is not dependent on it (Hyman et al., 1992, Vandecandelaere et al., 
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1999). However, the MT disassembly rate is regulated by GTP hydrolysis 
(Carlier et al., 1984). While the site for GTP hydrolysis is predominantly 
placed in the tubulin β subunit, some residues are also present in the α 
subunit. Hence hydrolysis is completed when both subunits form 
heterodimers upon head-to-tail assembly (Nogales et al., 1998). In neurons, 
microtubules are typically formed at the centrosome area. When ready, 
protofilaments are released by the MT-cutting protein katanin (Baas, 1999). 
At this point, stabilized by a variety of microtubule associated proteins, 
protofilaments can be transported to axons and dendrites (Nunez and 
Fischer, 1997).   
4.2  Microtubule-associated proteins (MAPs) 
Microtubule-associated proteins are divided into a couple of distinct groups. 
Some, like MAP1, MAP2, MAP4, tau or doublecortin (DCX), belong to 
structural MAPs, which stabilize and promote microtubule outgrowth. 
Others, like motor proteins, tightly yet transiently bind to tubulin which 
facilitates intracellular transport (Mandelkow and Mandelkow, 1995). The 
general organization of structural MAPs reveals their function in cross-
linking microtubules in the cytosol. They consist of two domains: basic 
tubulin interacting domain and an acidic projection domain, expanding from 
the microtubule surface and binding it to a variety of cellular structures 
including membranes, IFs or other microtubules (Lodish et al., 2000). MAPs 
coat the microtubule lattice and prevent the dissociation of tubulin hence 
regulating the rate of MAPs binding which can control the length of 
microtubules (Lodish et al., 2000). They work as anchors for a number of 
cytoplasmic proteins like protein kinases (Rubino et al., 1989, Serrano et al., 
1989) and other cytoskeleton related proteins (Selden and Pollard, 1983). 
Therefore the presence of a variety of different MAPs along the microtubule 
lattice may to some extent control structure and properties of microtubules at 
different stages during neuronal development (Chen et al., 1992).    
Sequence analysis of MAPs has further divided them into two types. 
Type I, comprised of MAP1A and MAP1B, is characterized by the presence 
of a number of acidic sequence repeats Lys-Lys-Glu-X (e.g. KKEV KKEI 
KKEE) thought to facilitate interaction with tubulin (Avila, 1991). These 
proteins form filamentous structures present both in axons and dendrites as 
well as in non-neuronal cells. The second type of MAPs consists of MAP2, 
MAP4 and tau. These MAPs contain 3-4 repeats of an 18-residue long 
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sequence present in the carboxy-terminal microtubule-binding domain. 
These sequences are divided by a sequence of inter repeats (Al-Bassam et 
al., 2002). MAP4 was previously found to be present in glial cells and in a 
variety of other non-neuronal tissues e.g. sertoli cells, cardiac, smooth or 
skeletal muscle (Parysek et al., 1984). Recently MAP4 has also been shown 
to be present in brain-specific cells including Purkinje cells in the 
cerebellum, and pyramidal neurons of the hippocampus (Tokuraku et al., 
2010). MAP2 and tau however, are brain specific MAPs enrolled in 
maintenance of microtubule dynamics in dendrites and axons, respectively 
(Drewes et al., 1998). Interestingly, the low molecular weight-MAP2 is 
expressed in axons and glial cells (Doll et al., 1993). In vivo studies revealed 
that the regulation of MAPs by phosphorylation influences their ability to 
bind to microtubules (Brugg and Matus, 1991). Moreover, phosphorylation 
affects the binding properties of MAPs in different ways. For instance, as 
shown by Itoh et al., (1997) when MAP2 is phosphorylated by protein 
kinase A (PKA) 70% of phosphates are found in the projection arm. 
However, when using cyclin B dependent kinase cdc2, over 60% of 
incorporated phosphates were distributed over the microtubule binding 
region. Importantly, the MAP2 protein, like MAP1B, is phosphorylated by 
JNK in vitro (Kyriakis and Avruch, 1990, Chang et al., 2003, Björkblom et al., 
2005).  Microtubule assembly is impaired in Jnk1-/- mouse brains where 
both MAP2 and MAP1B are hypophosphorylated, which in turn decreases 
their ability to bind and stabilize microtubules (Chang et al., 2003). It was 
moreover demonstrated that MAP2 is phosphorylated by JNK in intact cells 
and that this process plays a key role in maintenance of dendrite 
homeostasis (Björkblom et al., 2005).   
Tau, on the other hand, as a specific microtubule stabilizer in axons, 
forms neurofibrillary tangles when hyperphopshorylated in patients 
suffering from AD. Accumulation of hyperphosphorylated tau is clinically 
linked to loss of cognitive functions, mood disturbance, debilitating 
language and motoric skills (Huang and Jiang, 2011). Doublecortin, known 
as DCX, is yet another important MAP which is JNK’s pool of cytosolic 
substrates (Gdalyahu et al., 2004). Mutation in the X-linked DCX gene leads 
to abnormal brain lamination that results in smooth brain in males and 
double cortex in females, as a consequence of impaired neuronal migration 
(des Portes et al., 1998, Gleeson et al., 1999). Various mutations within the 
conserved region of Doublecortin domain impair DCX interaction with 
microtubules (Sapir et al., 2000). Three JNK phosphorylation sites (T331, 
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S334 and T321) found in DCX seem to play an important role in regulation 
of neurite length and cell migration (Bai et al., 2003, Gdalyahu et al., 2004). 
It was shown in PC12 cells that expression of unphosphorylable by JNK 
DCXT331A,S334A leads to neurite-like structures outgrowth inhibition. 
Conversely, the presence of pseudophopshorylated DCXT331E, S334E stimulated 
not only increased neurite length but also the total number of extensions 
(Gdalyahu et al., 2004).  
5.  Stathmin family proteins are potent microtubule 
destabilizers 
Stathmin is a small (19kDa) cytosolic, ubiquitously expressed 
phosphoprotein (Sobel et al., 1989, Ozon et al., 1997). It binds tubulin 
heterodimers, which leads to microtubule depolymerization (Belmont and 
Mitchison, 1996, Jourdain et al., 1997). Its expression level profile is tightly 
controlled during development and tissue regeneration (Koppel et al., 1990, 
Pampfer et al., 1992, Koppel et al., 1993, Okazaki et al., 1993a). Interestingly, 
stathmin overexpression in human sarcoma has been associated with cell 
migration and invasion (Baldassarre et al., 2005). While stathmin plays a 
significant role in spindle formation during cell-cycle progression, the other 
members of the family were found to participate in structural and functional 
plasticity of neurons (Riederer et al., 1997, Tararuk et al., 2006, Poulain and 
Sobel, 2007). The stathmin family proteins comprise of stathmin, SCG10, 
SCG10- like protein (SCLIP), RB3 and its two splice variants RB3’ and RB3’’, 
which is schematically represented in Figure 6 (Sobel et al., 1989, Ozon et al., 
1997, Ozon et al., 1998).   
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Figure 6. Schematic representation of stathmin family members. A. General 
scheme of all stathmin domains identified to date. Domain A and A’’ contain 
cysteine residues (indicated with an asterisk sign) that provide an anchor to the 
membrane. Unlike other family members, stathmin lacks domain A and cannot bind 
to membrane and remain cytosolic. B. Unlike the N-terminus, the C-terminus that 
contains a tubulin binding domain is highly conserved among family members. 
RB3’’ protein contains two additional A domains, namely A’ and A’’. 
Phopshorylation sites in all members are marked with letter P (Adapted from Mori 
and Morii, 2002). 
Detailed analysis of evolutionary relationships between members of the 
stathmin family revealed that SCG10 and SCLIP (most closely related to each 
other) originate from a mutual ancestral gene, although stathmin and RB3 
with its splice variants diverged earlier from the same gene (Ozon et al., 
1998). Rat RB3 was initially discovered as a homologue of a Xenopus B3 
(XB3) protein, whereas RB3’ and RB3’’ are the result of its alternative splicing 
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(Maucuer et al., 1993, Ozon et al., 1997). The RB3’ protein, due to an insertion 
of a stop codon within the tubulin biding domain, is approximately 13 aa 
smaller than RB3 (Okazaki et al., 1993b), whereas RB3’’ possess an additional 
A’’ 27 aa long sequence between domain A and A’ that is present also in RB3’ 
(Ozon et al., 1997, Ozon et al., 1998). Nevertheless they share a high degree of 
similarity with stathmin, which in fact is greater than with SCG10 (Ozon et 
al., 1997).   
Stathmin is most abundantly (about 0.25% of total protein content) 
expressed in the brain, where it is equally present in different cellular 
compartments (Gavet et al., 2002). It contains five putative phosphorylation 
sites (Ser 16, Ser 25, Ser 38, Ser 46 and Ser 63). All apart from Ser 46 have been 
shown to be phosphorylated both in vitro and in vivo by various kinases 
(Beretta et al., 1993). Most of those sites are conserved in SCG10 as well as in 
SCLIP, whose consensus phosphorylation sites are identical to those in 
SCG10 (Ozon et al., 1997, Ozon et al., 1998). Interestingly, RB3 and XB3 
protein contain only two conserved sites corresponding to Ser 16 and Ser 46 
(Ozon et al., 1997, Mori and Morii, 2002). RB3/RB3’ and RB3’’ proteins, unlike 
soluble stathmin, are localized to the perinuclear region labeling medial 
compartment of GA and growth cones (Gavet et al., 1998, Gavet et al., 2002). 
Due to the N-terminal extension, SCG10 and SCLIP are also associated with 
membranes and similarly to RB3s are present in the GA region, GA 
associated vesicles and growth cones (Lutjens et al., 2000, Gavet et al., 2002, 
Tararuk et al., 2006). SCG10 is present in the trans-GA compartment, whereas 
SCLIP appear in medial to trans region of GA (Lutjens et al., 2000, Poulain et 
al., 2008). Remarkably, contrary to stathmin, SCG10, SCLIP and RB3 with its 
splice variants are present in a very small population of cells (Gavet et al., 
2002).   
Stathmin is highly enriched in the brain, yet its expression is the highest 
during development and decreases postnatally (Gavet et al., 2002). Similarly, 
SCG10 expression can be found during early embryonic stages (E10.5-E11.5), 
yet its transcript declines after birth with few specific regional exceptions e.g. 
the olfactory bulb, the hippocampus and the cerebellum (Anderson and Axel, 
1985, Gavet et al., 2002, Mori and Morii, 2002). Conversely, SCLIP and RB3 
are present at a rather low level during early development, but their 
expression level peaks postnatally and mostly in adulthood (Ozon et al., 
1998).   
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The most prominent feature of stathmins is their role in the control of 
microtubule dynamics (Belmont and Mitchison, 1996, Jourdain et al., 1997, 
Curmi et al., 1999). They inhibit polymerization of tubulin or stimulate 
disassembly of microtubules in a process that is reliant on phosphorylation 
(Marklund et al., 1996, Steinmetz, 2007, Wang et al., 2007). It is well known 
that stathmins form a ternary T2S complex with tubulin by sequestering two 
α/β heterodimers (T2) per one molecule of stathmin (S) (Gigant et al., 2000, 
Wang et al., 2007). All family members contain a stathmin-like domain (SLD) 
that is responsible for interactions with tubulin and T2S complex formation. 
The overall arrangement of the T2S complexes is very similar among 
stathmins, however their stability is different (Jourdain et al., 2004, Wang et 
al., 2007). For instance, the T2S complex formed by RB3 has been shown to be 
more stable than the one with stathmin (Jourdain et al., 2004, Ravelli et al., 
2004, Steinmetz, 2007). There are two tubulin-binding sites within SLD and 
their positions are interchangeable and rearrangement of those greatly affects 
stability of the T2S complexes (Jourdain et al., 2004). A great amount of 
stathmin remains either hypophosphorylated or even unphosphorylated in 
cultured rat neurons. This in turn leads to sequestration of a significant 
amount of free tubulin, inducing catastrophe events (Gavet et al., 2002).   
Interestingly, knockout mice of stathmin develop normally and show no 
overt neurological or behavioral abnormalities when compared to the wild 
type cohort (Schubart et al., 1996). However with age, knockout mice develop 
axonopathy observed both in the central and the peripheral nervous system 
(Liedtke et al., 2002) similar to a condition noted in Jnk1 knockouts mice 
(Chang et al., 2003). Although stathmin is enriched in the amygdala, no clear 
anomalies in morphology of pyramidal cells of the lateral amygdala were 
observed in the knockout mice. Similarly, CA1 hippocampal neurons seemed 
unaffected by depletion of stathmin (Shumyatsky et al., 2002, Shumyatsky et 
al., 2005). Additionally, in rat PC12 cells, depletion of stathmin prevented 
their differentiation into sympathetic-like neurons following NGF 
stimulation (Di Paolo et al., 1997b). Furthermore, the total dendrite length 
was decreased in Purkinje cells when stathmin expression was silenced with 
siRNA (Ohkawa et al., 2007). Unlike in D. melanogaster, where a single gene 
encodes the whole family of stathmins, in vertebrates some functional 
redundancy is expected among different family members. Hence the 
knockout phenotype seems rather mild in mice, but not in the fruit fly, where 
inactivation of stathmin with RNAi leads to cell migration arrest, loss of 
commissures, and other serious anomalies (Ozon et al., 2002).  
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5.1  JNK substrate Superior Cervical Ganglion 10 protein (SCG10) 
Unlike ubiquitously expressed, soluble stathmin (Sobel et al., 1989), SCG10 is 
a neuron-specific and membrane-associated protein, although it is not an 
integral part of the membrane (Stein et al., 1988a). Initially, SCG10 was 
discovered during a screen of neural crest-derived cells (Anderson and Axel, 
1985). Its expression is under control of neural restrictive silencer (NRS), 
which in non-neuronal cells binds to neural restrictive silencer 
factor/repressor element-1 silencing transcription (NRSF/REST), hence 
suppressing SCG10 expression (Mori et al., 1992). The NRSF/REST is 
predominantly expressed in non-neuronal cells as well as in undifferentiated 
neurons. Its expression however declines upon neuronal maturation 
(Armisen et al., 2002).  
In the brain, it has been shown that SCG10 associates with punctuate 
structures accumulating in the perinuclear cytoplasm of developing neurons 
(Stein et al., 1988a). Its expression is developmentally upregulated and peaks 
during differentiation of central and peripheral neurons (E10-E11) and 
declines within a few weeks of postnatal development (Sugiura and Mori, 
1995). Similarly, cultured cortical neurons present high level of SCG10 during 
neurite outgrowth, yet after the formation of synapses the amount of protein 
is dramatically decreased (Di Paolo et al., 1997a). In general, the level of 
SCG10 significantly declines in adulthood. However, it persists in the regions 
of synaptic plasticity, including long-distance projection neurons and 
neurons with extensive dendritic arborisation (Himi et al., 1994). SCG10 and 
stathmin share 70-80% sequence homology within the conserved region 
(Mori and Morii, 2002). Moreover, the SCG10 gene originated from stathmin 
by the duplication and additional modification of the ancestral stathmin gene 
(Okazaki et al., 1993b). In contrast to stathmin, SCG10 has an amino-terminal 
extension necessary for its membrane targeting and GA localization (Figure 
6) (Di Paolo et al., 1997b, Di Paolo et al., 1997c). Two cysteine residues (Cys 
22 and Cys 24) within the amino-terminal domain are essential for GA 
sorting and growth cone targeting of SCG10 (Lutjens et al., 2000). As a result 
of its distribution in the central domain of a growth cone, where population 
of highly dynamic microtubules accumulate, it is considered to be a 
regulatory factor of microtubule dynamics (Grenningloh et al., 2004). It has 
previously been shown that overexpression of SCG10 stimulates neurite 
outgrowth in neuronal cells, which is thought to be dependent on dynamic 
instability of microtubules (Riederer et al., 1997).   
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SCG10 contains several phosphorylation sites. It has been shown that 
protein kinase A (PKA) phosphorylates SCG10 on Ser 50 and Ser 97, while 
Ser 62 and Ser 73 are targets for MAP kinases. Additionally, Ser 73 can be 
utilized by the cyclin dependent kinase (Antonsson et al., 1998).  
In contrast to the developing brain, the adult brain has very little capacity 
of regeneration. There are, however, a few regions where this ability has been 
retained. These are for instance the ventricular zone, the olfactory bulb, and 
the dentate gyrus (Cameron and McKay, 2001). It was found that SCG10 and 
JNK are present in the pyramidal neurons of CA1 and CA3 region of the 
hippocampus in four months old mouse brains. Furthermore, both proteins 
were found in two types of cells in the olfactory bulb. These are mitral and 
periglomerular cells (Westerlund et al., 2008).  
Interestingly, it was shown that Ser 73 may be phosphorylated in response 
to kainate stimulation and might be a target for another MAP kinase (Morii 
et al., 2006). Injection of the stimulant led to NMDA receptor activation and 
induction of the Ras-Erk2 pathway, which in turn induced phosphorylation 
of SCG10 on Ser 73 (Morii et al., 2006). Importantly, activation of NMDA 
receptors in postsynaptic area results in dephosphorylation of MAP2 protein 
(Halpain and Greengard, 1990, Quinlan and Halpain, 1996). This shift could 
potentially lead to more stable microtubules; hence the synaptic connection 
could take on a firmer structure consequently intensifying synaptic efficiency 
(Morii et al., 2006). It is however important to mention that no other kinases 
were tested in the proposed model.  
5.2  Microtubule destabilizing activity of SCG10 in the nervous 
system 
Similar to stathmin, SCG10 can form a ternary complex with tubulin by 
binding its heterodimers (Fleury et al., 2000, Charbaut et al., 2001). Upon 
phosphorylation, this interaction can be abolished as shown both in vitro and 
in intact cells (Gavet et al., 1998). Like stathmins, SCG10 can influence 
microtubule stability by plus-end stabilization and minus-end catastrophe 
events (Riederer et al., 1997, Howell et al., 1999, Togano et al., 2005). 
However, it seems that the minus-destabilizing activity is more favorable 
than the stabilizing effect at the plus-end (Manna et al., 2007).   
In an in vitro assay SCG10 hinders polymerization of microtubules in a 
dose dependent manner (Grenningloh et al., 2004). It can be as efficient as 
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stathmin in inducing catastrophe. It not only co-purifies with microtubules 
but in addition, it may neutralize the stabilizing effect of taxol (Riederer et al., 
1997). It has been demonstrated that SCG10 is phosphorylated both in vitro 
and in vivo by JNK (Tararuk et al., 2006). The presence of JNK is crucial 
during embryonic development as well as in adulthood where it plays a role 
in defining neuronal cytoarchitecture (Kuan et al., 1999, Björkblom et al., 
2005). Interestingly, Tararuk et al. (2006) found that when regulated by JNK, 
SCG10 is in control of axodendritic length. Expression of SCG10 62A/73A, an 
unphosphoryable by JNK form of SCG10, hindered recovery of tubulin by 
50% in photobleaching experiments. As previously mentioned, stathmins 
comprise of two separate tubulin-binding motifs and sequestration of free 
tubulin leads to depolymerisation of microtubules at the minus end (Gigant 
et al., 2000). It is indeed intriguing that SCG10 can stabilize microtubules at 
the plus-end (Manna et al., 2007). The GTP-bound tubulin is known to 
connect tightly to other subunits within the microtubule lattice; hence the 
GTPase activity plays an essential role in separating tubulin heterodimers 
from the plus-end. Importantly, stathmins decrease the GTPase activity of 
tubulin dimers when incorporated into the protofilament (Wang et al., 2007). 
Therefore, one may expect stathmins to stabilize the plus end of microtubules 
containing recently added, GTP-bound tubulin (Westerlund et al., 2008).  
Moreover the connection formed between zippered and unzippered 
microtubule lattice revealed that protofilaments undertake an outward twist, 
which is similar to that formed by tubulin heterodimers when bound to 
stathmin (Gigant et al., 2000). Hence it may be advantageous energy-wise for 
SCG10 to bind to tubulin exposed at the zipper junction (Westerlund et al., 
2008).   
5.3  The role of SCG10 in the disease state and neuronal 
regeneration 
Although under physiological conditions SCG10 is present only in cells of the 
central and peripheral nervous system, an anomalous expression of SCG10 
mRNA was noticed in nonsmall lung carcinoma cell lines which are lacking 
NRS binding proteins Brm and BrG (Watanabe et al., 2006). Moreover, a 
recently published report indicates that SCG10 contributes to an aggressive 
phenotype of gastric cancer (Guo et al., 2013). A variety of diseases that involve 
architectural remodeling as in the case of Budd-Chiari syndrome, describe 
upregulation of SCG10 expression (Paradis et al., 2005). Budd-Chiari syndrome 
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is characterized by obstruction of the hepatic venous system in young adults 
and the character of the disease may be acute, subacute and chronic (Valla and 
Benhamou et al., 1999). Upregulation of SCG10 was observed in the chronic 
phase, associated with extensive liver fibrosis (Paradis et al., 2005). During 
axon regeneration in the olfactory epithelium not only SCG10 but also 
stathmin is upregulated following injury (Pellier-Monnin et al., 2001). In 
addition, high levels of SCG10 are observed following stroke during a period 
of axonal sprouting in the peri-infarct cortex (Carmichael et al., 2005). 
Moreover, SCG10 mRNA increases within 72 h of a post-sciatic nerve crush 
and remains elevated up to 2 weeks post injury. The decline in mRNA level in 
the PNS is associated with re-innervation of the target (Mason et al., 2002). 
Interestingly, in another model of nerve injury a marked increase in SCG10 
mRNA was noticed (Iwata et al., 2002). Although other family members of 
mRNAs were also induced, SCG10 appeared the quickest but similarly to 
others declined to control levels after a few weeks (Iwata et al., 2002).  
A recent report from Shin et al., (2012) further indicates a role for SCG10 
in preventing degeneration of transected axons in dorsal root ganglion 
neurons. They suggest that preservation of SCG10 levels post injury in the 
distal part of axons endorses movement of mitochondria and therefore 
postpones degenerative processes. Consequently, SCG10 is likely to be a 
moderator of regenerative processes, although the definite proof is still 
missing. Nevertheless we know nowadays that SCG10 is one of the key 
molecules in growth cone progression. Blockage of SCG10 function induces 
redistribution of the growth cone cytoskeleton, followed by pauses in 
expansion of an axon (Suh et al., 2004). Moreover, it has been suggested that 
SCG10 may participate in the remodeling of presynaptic terminals, since 
long-term potentiation induced its upregulation in rat hippocampal neurons 
(Peng et al., 2003). Conversely, SCG10 mRNA was downregulated in answer 
to monocular lack of visual stimulus in macaque monkeys, when shown by 
in situ hybridization (Higo et al., 2000). Currently it is believed that both 
SCG10 and stathmin have crucial roles in axonal outgrowth throughout the 
early developmental stages and during regenerative processes in adulthood. 
Yet few studies have implicated SCG10 and stathmin in neurodegenerative 
disorders. The work done by Okazaki and co-workers showed that in 
Alzheimer’s patients neither the mRNA nor protein level of SCG10 or 
stathmin is affected, nevertheless SCG10 immunoreactivity in neuronal cell 
bodies is increased in AD-affected brain regions, which futher suggests 
impairment in axonal transport. Furthermore correlation analysis showed 
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that there is a positive correlation between the number of neurofibrillary 
tangles (NFTs) and SCG10 protein levels. This in turn suggests that the 
changed SCG10 compartmentalization and metabolism may contribute to 
events involved in tangle formation (Okazaki et al., 1995).  
Recently, processing of amyloid precursor protein (APP), which plays a 
crucial role in pathogenesis of AD, has been linked to SCG10. It has been 
shown that SCG10 may be involved in nonamyloidogenic processing of APP 
by interacting with APP’s intracellular part. High levels of SCG10 were 
associated with APP accumulating in post-Golgi vesicles and the cell surface 
(Wang et al., 2013).  
SCG10 abnormal gene expression has also been reported in neurospheres 
from Down syndrome fetuses (Bahn et al., 2002). It was observed that 
neuronal precursors from the diseased brains showed severe deficiency in 
regulation by NRSF/ REST genes. As a consequence, it led to almost complete 
loss of SCG10 expression and had a severe impact on neuronal 
differentiation. Notably, stathmin expression is also affected in Down’s 
syndrome (Cheon et al., 2001).    
6.  Excitotoxic stress in the brain 
Glutamate is the principal excitatory neurotransmitter in the mammalian 
brain. Its activation is essential for proper synaptic plasticity. It plays a key 
role in learning processes as well as development of the central nervous 
system. However, its action at the synaptic cleft needs to be well regulated. 
An excessive release and insufficient reuptake of excitatory 
neurotransmitters may lead to excitotoxicity, which ultimately results in cell 
death (Nicholls and Attwell, 1990). In 1957, for the first time, Lucas and 
Newhouse demonstrated neurotoxic properties of glutamate by systemic 
delivery of glutamate to newborn mice, which in turn led to retinal 
degeneration (Lucas and Newhouse, 1957). Glutamate is a non-essential 
amino acid that is unable to pass through the blood-brain barrier (BBB), 
hence it needs to be produced by neurons using available precursors e.g. 
glutamine or glucose. Excitatory amino acid transporters (EAAT) are 
responsible for proper management of glutamate amounts in the synaptic 
cleft. That results in tenfold higher concentrations of glutamate inside the cell 
than outside (Maragakis and Rothstein, 2001).   
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There are two types of glutamate receptors in the human brain, known as 
metabotropic (mGluR) and ionotropic (iGluR). The metabotropic receptors 
are part of the G-protein-coupled receptors (GPCR) superfamily. In contrast 
to iGluRs, mGluRs produce lengthier postsynaptic responses that either 
intensify or reduce the excitability of postsynaptic cells. Hence the 
physiological responses they elicit may differ (Niswender and Conn, 2010). 
iGluRs are nonselective cation channels that permit Na+, K+ and in some cases 
Ca2+ ions to pass. Named after their agonists: NMDA (N-methyl- D-
aspartate), AMPA (αamino-3-hydroxyl-5-methyl.4.isoxazole-propionate) and 
kainate, iGluRs elicit excitatory responses (Madden, 2002). Upon release, 
newly synthesized glutamate may bind to iGluRs present in the postsynaptic 
membrane, which in turn leads to their activation. Often glutamate toxicity 
can result from excessive stimulation of NMDA receptors (NMDAR) in 
particular (Choi et al., 1988). It has been demonstrated that extreme 
activation of NMDAR is partly responsible for pathological processes 
associated with different forms of neuronal insult including stroke, status 
epilepticus and a variety of neurodegenerative disorders (Hynd et al., 2004). 
The excitatory postsynaptic potentials (EPSPs) created by overstimulation of 
NMDA receptors leads to Ca2+ influx which, when excessive, may cause 
excitotoxic death. The sudden entry of Ca2+ combined with excessive 
NMDAR activity is believed to play a crucial role in mediating neuronal cell 
death (Arundine and Tymianski, 2003).  
6.1  Structure of NMDA receptors 
To date, three subfamilies of NMDAR subunits have been described. These 
are i) the NR1 subunit, ii) NR2A, 2B, 2C, 2D and iii) two NR3 subunits A and 
B (Van Dongen, 2009). The NR1 subunit is associated with the functional 
NMDAR and has several splice variants, which may affect the properties of 
the channel. Structurally NMDAR are heterotetramers, comprised of two 
NR1 subunits and two NR2 or NR3 subunits (Papadia and Hardingham, 
2007). Due to great variability in the electrophysiological profiles of NR2 
subunit it potentiates the activity of the channel adjusting the functional 
properties of the receptor (Madden, 2002). The most recently discovered NR3 
requires interaction with the NR1 subunit for correct membrane placement 
(Perez-Otano et al., 2001).   
In general, all ionotropic receptors show a similar structural design. They 
consist of i) an extracellular N-terminal domain (NTD), a 400 aa long 
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sequence which plays a role in proper assembly of the receptor, trafficking 
and its function, ii) the S1S2 ligand-binding domain (LBD) which is followed 
by a re-entrant loop domain outlining the ion channel as well as iii) the 
intracellular C-terminal tail of NMDAR which connects the receptor to 
various signaling cascades (reviewed in Madden, 2002).  
NMDARs possess unique properties. Apart from permitting entry of 
different ions they also bind extracellular Mg2+, which under resting 
potentials blocks the pore of NMDAR. However, this blockage is current-
dependent and depolarization forces ion out allowing passage of other 
cations (Popescu and Auerbach, 2004). Another interesting feature of 
NMDAR is that opening of the channel needs a co-agonist, e.g. glycine or D-
serine, which can bind to the NR1 subunit (Shleper et al., 2005).    
Table 5. Summary of the NMDAR expression pattern 
Based on Ewalds and Hollins , 2009  
Subunit   Expression time Brain region 
NR1  Starts E14   
Peaks P21  
• Homogenous expression throughout brain 
NR2A  Starts P0    
Peaks P14  
• Hippocampus 
• Cortex  
• Throughout brain (P14 onwards)  
NR2B  Starts E14  
  
• Prenatal cortex 
• Thalamus  
• Spinal cord  
• Colliculi  
• Hippocampus  
• Hypothalamus 
NR2C  Starts P0   
Peaks P21  
• Cerebellum 
• Forebrain 
NR2D  Starts E14  
Peaks P7  
• Diencephalon 
• Mesencephalon  
• Spinal cord   
• Cortex  
• Hippocampus  
• Septum 
NR3A  Starts E15  
Peaks P8  
• Spinal cord 
• Medulla  
• Pons  
• Tegmentum  
• Hypothalamus  
• Thalamus 
NR3B  Peaks P14  • Motor neurons of the brain stem 
• Spinal cord  
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The development of glutamatergic synapses is essential for proper brain 
function. Although there are numerous components that modulate synapse 
growth, synaptic activity is one of the key elements. In the early stages of 
development this function is mainly governed by the NMDAR (Durand et 
al., 1996, Wu et al., 1996a, Aizenman and Cline, 2007). The expression time 
for NMDAR subunits starts at around E14-15 (Table 5). All members of the 
NMDAR family show diverse yet overlapping expression patterns during 
development, which is summarized in Table 5 (Cull-Candy and Leszkiewicz, 
2004).   
The NR1 subunit shows the highest expression level at around three 
weeks post delivery, and later on it drops, reaching adult levels (Paupard et 
al., 1997). Some isoforms are expressed equally throughout the brain whereas 
some show a more restricted pattern in the cortex or hippocampus (NR1-1), 
or thalamus and cerebellum (NR1-4) (Laurie and Seeburg, 1994, Lee-Rivera et 
al., 2003). Among the NR2 subunits only NR2B and NR2D have been 
detected in embryos. Unlike NR2B, which is present in the developing cortex, 
thalamus and spinal cord, NR2D is expressed in the diencephalon, 
mesencephalon and in the spinal cord. At P0 NR2A begins to appear in 
hippocampus and NR2C mRNA can be detected in cerebellum (Cull-Candy 
et al., 2001). Similar to NR1 subunits the expression levels of various NR2 
isoforms starts to decline after the first three weeks of life (Monyer et al., 
1994). For example, NR2B and NR2D, although highly expressed in 
embryonic brain during development, are supplemented with or even 
replaced by NR2A and 2C (Cull- Candy et al., 2001). The most recently 
discovered NR3A and NR3B subunits are present in embryos showing a 
differential expression pattern (Sucher et al., 1995, Nishi et al., 2001). 
Interestingly, NR3s reach the highest expression level about 2 weeks post 
delivery and remain high throughout later life (Matsuda et al., 2002).  
6.2  Functional role and clinical risks of NMDA receptors activation 
Transgenic animals lacking single NMDAR subunits show no overt brain 
malformation. However, they die briefly after birth for various reasons 
including respiration failure (NR1-/-) or lack of suckling responses (NR2B-/-) 
(Forrest et al., 1994, Kutsuwada et al., 1996). The synaptic activity, which is 
essential for the incorporation of new neurons into existing neural circuits, is 
diminished in these animals (Sakimura et al., 1995, Tashiro et al., 2006). 
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Interestingly, deletion of other NMDAR subunits does not alter viability and 
mice mature (Kadotani et al., 1996).  
It has been shown that blocking NMDA receptors in vivo leads to an 
increased level of cell death, especially among cerebellar granule neurons 
(CBGs) (Monti and Contestabile, 2000). Moreover, the survival rate of CBGs 
in culture is severely impaired upon NMDAR blockage (Ciani et al., 1997). 
Furthermore, it was found that NMDAR antagonists in spinal cord cultures 
stimulate death rate by hindering electrical activity (Brenneman et al., 1990). 
Interestingly, the cAMP-response-element-binding-protein (CREB) is thought 
to mediate pro-survival responses in answer to NMDAR stimulation 
(Mantamadiotis et al., 2002). Following ischemia and exposure to glutamate, 
entry of Ca2+ triggers phosphorylation of CREB at Ser133, which in turn has 
neuroprotective implications (Walton and Dragunow, 2000). However, 
activation of extrasynaptic NMDAR have an opposing effect on CREB and 
stimulate cell death (Hardingham et al., 2002). During ischemia, the balance 
of glutamate, which is normally managed by glutamate transporters, is 
severely impaired. In addition, instead of removing the excess of glutamate, 
the transporters release it to the extracellular space leading to extrasynaptic 
NMDAR activation and cell death (Rossi et al., 2000). While entry of Ca2+ 
through activation of extrasynaptic receptors may lead to phosphorylation of 
CREB, it does not result in pro-survival gene stimulation but leads to cell 
death (Rossi et al., 2000). This implies that the spatial localization of 
NMDARs may influence their downstream action; promoting either survival 
or death (Hardingham et al., 2002).   
During development, NMDAR excitatory neurotransmission plays a 
fundamental role in establishing synaptic connections and refinement of 
functional circuits. Their activity is critical for mechanisms involved in 
learning and memory; then again glutamate toxicity is an indisputable source 
of neural damage during stroke and neurodegenerative diseases including 
AD, ALS or Huntington’s disease (Riccio and Ginty, 2002, Papadia and 
Hardingham, 2007). These contradictory functions of NMDARs may provide 
some explanation as to why there is poor tolerance and effectiveness of 
NMDAR antagonist used in clinical trials following excitotoxic insult. 
Furthermore, blocking NMDAR compromises normal brain function, leading 
to serious neurological and psychiatric consequences (Gilmour et al., 2012, 
Lakhan et al., 2013).  
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It is worth remembering that the character of various disorders in which 
excitotoxicity has been involved shows, that most likely there are variations 
in the basic excitotoxicity process. Since the starting events may be of a 
various nature including: vascular/ ischemic, as seen in stroke, genetic, 
metabolic or immunologic, then both the temporal and anatomical features 
may be significantly different (Lynch and Guttman 2002). The differences 
among excitotoxicity models may also reflect the activation of receptors other 
than NMDA, like AMPA/kainate receptors activated in multiple sclerosis 
(Pitt et al., 2000). Finding the main post-receptor signaling event responsible 
for cell death could therefore provide a target for potential therapeutic 
interventions and save the lives of many people suffering from various 
neurodegenerative diseases.  
6.3  The role of JNK in excitotoxicity  
Excitotoxocity has been linked to many brain injuries over the years, as has 
been the JNK kinase. A pivotal study assessing the role of JNK in excitotoxic 
death was based on studies done in Jnk3 knockout mice. Jnk3-/- mice 
presented reduced seizures as well as decreased cell death in response to 
systemic administration of kainite (Yang et al., 1997). It has been shown that 
kainite stimulates expression of c-Jun and c-Fos, the AP-1 complex proteins, 
leading to activation of JNK in the hippocampus (Yang et al., 1997). In 
addition, mutant mice of c-jun, in which JNK phosphorylation sites are 
mutated to alanines, showed resistance to excitotoxic insult. This implies that 
blocking JNK from accessing c-Jun may have a neuroprotective effect 
(Behrens et al., 1999). Interestingly, the Jnk3 knockout mice resemble the 
glutamate receptor 6 (GluR6) deficient mice phenotype very much (Mulle et 
al., 1998). It was thus hypothesized that JNK may take part in GluR6 
mediated excitotoxicity (Mulle et al., 1998).   
Furthermore, it was shown that post-synaptic density protein (PSD-95) 
may provide a link between JNK and GluR6 (Savinainen et al., 2001). Post 
synaptic density proteins act to arrange a signaling matrix. It was shown that 
PSD95 may anchor two upstream activators of JNK, MLK2 or MLK3 (Garcia 
et al., 1998, Savinainen et al., 2001), and deletion of the binding site for GluR6 
on PSD95 significantly decreased activation of JNK and cell death. Moreover, 
the presence of dominant–negative MLK2 or MLK3 considerably reduced 
JNK activation (Savinainen et al., 2001). In cortical neurons, it was previously 
shown that activation of NMDAR leads to JNK activation already within 1 
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min of post-excitotoxic insult. Moreover, JNK activity remains high for the 
first 30 min, after which it slowly declines. This response was demonstrated 
to be dependent on flux of extracellular Ca2+ (Ko et al., 1998).  
6.4  Animal models: 
6.4.1 Middle Cerebral Artery Occlusion (MCAO) model of stroke 
Stroke is one of the major causes of death and the foremost source of 
disability in the US (Rosamond et al., 2008). Although in a great majority of 
cases ischemic stroke is responsible, there is only one therapy approved for 
use during the acute phase. It is the thrombolytic tissue plasminogen 
activator (tPA) (Armstead et al., 2010). To date four main ischemic stroke 
models have been studied, namely complete global cerebral ischemia, 
incomplete global ischemia, focal cerebral ischemia (including MCAO) and 
multifocal cerebral ischemia (Graham et al., 2004).   
The MCAO is most often used to mimic human condition in an animal. It 
is due to the fact that, in majority of cases, the ischemic stroke is a 
consequence of a thrombotic or else embolic occlusion found in the middle 
cerebral artery (MCA) (Durukan and Tatlisumak, 2007). The cerebral blood 
flow in the core of the infarct drops dramatically from 50-60mL/100g/min to 
less than 7mL/100g /min and so the damage in that region is permanent. 
However, the core is surrounded by so-called penumbra, where blood flow is 
retained at a level of 7 -17mL/100g/min. Although this region is electrically 
silent, metabolic activity can still be detected (Astrup et al., 1981, Baron, 
1999). An excess of glutamate appears subsequently to cerebral ischemia 
(Budd, 1998). The core of the infarct emanates peri-infarct depolarizations 
(PIDs) towards the penumbra region. The PIDs can be a consequence of 
glutamate release or else K+ and Ca2+ ions. The number of PIDs increases with 
the size of the infarct (Mies et al., 1993). In practice, their presence is useful as 
a tool to differentiate between the core and the penumbra (Ohta et al., 2001).   
Calcium overload is an obvious consequence following release of 
glutamate, so are reactive oxygen species generated during an ischemic 
attack. They have been shown to act on several intracellular signaling 
pathways resulting in detrimental consequences. One such candidate is the 
p38 MAPK pathway, which is activated during stroke (Cao et al., 2005). 
Cerebral ischemia interrupts the blood-brain-barrier (BBB), damaging the 
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tight junctions of endothelial complexes (Mark and Davis, 2002). 
Modification in the structure of the BBB recruits leukocytes to the site, which 
in turn leads to activation of inflammatory cascades and additional cerebral 
damage (Huang et al., 2006). It used to be considered that necrotic death is a 
hallmark of ischemia. However, a few hours post ischemic attack, neurons 
suffer transient reversible damage, after which they undergo apoptosis 
(Linnik et al., 1993, Charriaut-Marlangue, 1998). The complexity of the 
responses elicited following an ischemic infarct makes further research 
indispensable in order to generate effective neuroprotective approaches.  
6.4.2  Pilocarpine-induced status epilepticus 
Approximately 50 million people around the globe suffer from epilepsy 
(Sander, 2003). There are several risk factors that account for development of 
epilepsy and these are: cerebrovascular diseases, brain cancer, alcohol, 
traumatic head injuries, defects in cortical development, genetic aspects as 
well as infections of the CNS, or malaria in less developed countries (Duncan 
et al., 2006). Spontaneous repeated seizures are a hallmark of epilepsy. They 
result from focal or general sudden variations in neurological functions 
caused by atypical electrical activity observed in the cortex (Shin and 
McNamara, 1994). This is due to lack of balance between the two most 
important neurotransmitters: GABA (inhibitory) and glutamate (excitatory) 
(Dalby and Mody, 2001). There are two types of convulsions: partial and 
general. In case of generalized seizures both hemispheres misfire at the same 
time, unlike in partial convulsions, where the local onset of epilepsy may 
spread to other brain regions (Duncan et al., 2006).  
Administration of pilocarpine, which is a strong agonist of muscarinic 
receptors, leads to consecutive changes at both the behavioral and 
electrographic level in the rat model of epilepsy. Among those changes we 
can distinguish three different periods. The first one is an acute phase that 
evolves into a limbic status epilepticus lasting for about 24 h. It is followed by 
a silent period during which both electroencephalography (EEG) readout 
and behavioral changes normalize. The length of this period varies from 4 to 
44 days. Finally the last, third period, is a chronic one and is characterized by 
spontaneous recurrent seizures (SRSs) (Cavalheiro, 1995). Systemic 
administration of pilocarpine acts on either M1 or M2 muscarinic receptors. 
Activation of the M2 receptor type leads to inhibition of adenylate cyclase, 
which in turn causes reduction of acetylcholine release and neuronal 
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activation. Conversely, activation of M1 leads to phospholipase C activation 
and production of diacyloglycerol (DAG) and inositol triphosphate (IP3). 
That leads to modifications in the Ca2+ and K+ current resulting in high 
excitability of the brain tissue (Segal, 1988).  Increased levels of Ca2+ trigger 
glutamate release and induce status epilepticus. The excitotoxic insult triggers 
instant cell death occurring within minutes after application of pilocarpine, 
but also leads to neurodegeneration extended over weeks and months (Leite 
et al., 1990, Cavalheiro, 1995). The acute phase is characterized by increased 
level of glutamate, which in turn leads to activation of the NMDAR resulting 
in cell death (Costa et al., 2004). It has been shown that the level of neuronal 
damage correlates with the severity and duration of the seizures (Covolan 
and Mello, 2006). The neuronal damage observed after epileptic seizures has 
been found in various brain areas, including the hippocampus, thalamus, 
amygdala as well as various cortical regions (Fabene et al., 2007).  
7.  The role of JNK in neurodegeneration 
The range of diseases that JNK is involved in is very broad and it 
encompasses various neurological, coronary, respiratory, hepato-biliary, 
autoimmune, inflammatory, metabolic disorders as well as multiple forms of 
cancer (Sabapathy, 2012). However, for the scope of this thesis, the attention 
will be brought to the role of JNK in selected neurodegenerative syndromes.  
7.1  Stroke 
Activation of the JNK signaling cascade is associated with ischemia. In a 
transient in vivo model of global ischemia, active JNK, p38, as well as ERK 
were found already active within 5 minutes in the CA1 and CA3 region of 
the hippocampus (Sugino et al., 2000). Following reperfusion, activity of JNK 
and p38 were enhanced for the next 72 h. Moreover, in the proposed model 
of transient ischemia, administration of the p38/JNK inhibitor SB203580 
decreased cell death, unlike when MEK-ERK inhibitor PD98059 was 
administered (Sugino et al., 2000). In addition, administration of the JNK 
inhibitor SP600125 reduced apoptosis in the CA1 region of the hippocampus 
in a model of mild ischemia (Guan et al., 2005). In another model of transient 
focal cerebral ischemia, 60 min occlusion of the middle cerebral artery was 
sufficient to induce JNK activity in the MCA region. Administration of 
SP600125 prevented apoptotic death, as measured by TUNEL assay. It was 
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proposed that JNK death signals are transmitted via interaction with BimL 
and further downstream via Bax. The JNK-BimL interaction was blocked 
upon inhibitor treatment (Okuno et al., 2004). Importantly, these findings 
were further verified by another study using SP 600125. Presence of the 
inhibitor not only reduced JNK activity but also diminished the size of the 
infarct in a dose-dependent manner (Gao et al., 2005). In addition, inhibition 
of JNK resulted in decreased expression of Bim and Fas, but not Bcl-2 or 
FasL. In other words, inhibition of JNK stopped the ischemia-induced Bax 
and Bim translocation to mitochondria, thus preventing the release of 
cytochrome c that normally results in cell death (Gao et al., 2005).  
So far, administration of tPA within a few hours following ischemic attack 
is recommended as a primary choice treatment. Interestingly, development 
of a peptide inhibitor called DJNKI1 has brought many promising results for 
JNK suppression in stroke models. DJNKI1 is a D-retroinverso peptide 
inhibitor of JNK kinase. It consists of a 20 aa sequence derived from the JIP1 
protein, which is the JNK-binding domain of JIP1 (Centeno et al., 2007). The 
in vitro approach with cortical neurons treated with NMDA showed that 
DJNKI1 confers protection to cortical neurons treated with NMDA (Borsello 
et al., 2003). Moreover, in the in vivo transient model of stroke, DJNKI1 has 
significantly reduced the size of the lesion, despite late application (6 h after 
the lesion). The reduction of the lesion size corresponded with improved 
animal behavior (Borsello et al., 2003). This implies that the potential 
therapeutic time window could be twice that of tPA. It was further shown 
that late administration of DJNKI1 to hippocampal slices deprived of glucose 
and oxygen for 30 min significantly reduced the amount of cell death. In 
addition, when DJNK1 was used in the same study but in a permanent 
occlusion model of stroke, it substantially reduced the size of the infarct 
within 3 h (Hirt et al., 2004). Importantly, DJNKI1’s function is not impaired 
in the presence of tPA and the peptide inhibitor was still providing 
neuroprotection both in vitro and in vivo (Wiegler et al., 2008). Nonetheless, 
following ischemic attack, the JNK cascade is also activated in other cell types 
apart from neurons, including glia or the brain endothelium (Xie et al., 2004b, 
Kacimi et al., 2011). This may in turn have an undesirable impact on neuronal 
survival. However, it was presented that DJNKI1, when delivered 
peripherally, may affect some of the inflammatory processes in non-neuronal 
population of cells (Benakis et al., 2010). Therefore, we should hope that 
DJNKI1 will pass all clinical tests required for future human use, and that it 
will be beneficial to all patients suffering from stroke.  
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7.2  Wallerian degeneration 
Behind the pathology associated with traumatic, inflammatory or 
degenerative neurological diseases lies deterioration of the axon. Growing 
evidence indicates that axonal degeneration appears early on during the 
progression of the disorder. Therefore, it is an important target in terms of 
future therapies (Lingor et al., 2012). Originally discovered by Waller in 1850 
in transected glossopharyngeal and hypoglossal nerves, Wallerian 
degeneration refers to degenerative processes initiated in the distal-to-the-
injury part of an axon. Following injury, the parts of an axon which are 
unaffected by acute degeneration remain morphologically stable for about 
24-72 h. After that, the distal part goes through gradual fragmentation 
resembling the acute axonal degeneration, eventually leading to its total 
elimination (Kerschensteiner et al., 2005).   
Activation of various kinases including JNK plays an important role in 
progression of degeneration (Lingor et al., 2012). It is widely known that 
JNK, apart from its prominent role as a stress kinase, governs many 
physiological functions in neurons (Coffey et al., 2000, Coffey et al., 2002, 
Björkblom et al., 2005, Kyriakis and Avruch, 2012). Mice lacking Jnk1 display 
abnormal axonal tracks (Chang et al., 2003). Moreover, JNK has been shown 
to control the transcriptional events involved in neurite outgrowth in PC12 
cells as well as axon regeneration in dorsal root ganglion (DRG) neurons 
(Yao et al., 1997, Kenney and Kocsis, 1998). In addition, activated JNK is 
needed for axon formation. Blocking JNK also inhibits axogenesis but does 
not counteract dendrite formation (Oliva et al., 2006).  
Nerve injury elicits many changes both in severed neurons and in the 
neighboring non-neuronal cells, which eventually lead to effective 
reinnervation or else commit cells to death (Cavalli et al., 2005). Transection 
of the sciatic nerve leads to activation of c-Jun and the presence of activated 
JNK in the cell body (Jenkins and Hunt, 1991, Kenney and Kocsis, 1998). In 
addition, it was shown that in the sciatic nerve, JNK is transported 
bidirectionally at high rates (Middlemas et al., 2003). A study from the 
Goldstein laboratory proposed that pJNK, via its interaction with Sunday 
Driver (syd), could be part of a vesicular damage surveillance system in 
severed peripheral nerves (Cavalli et al., 2005). Using olfactory receptor 
neurons as an axonal lesion model in D. melanogaster and transection of 
sciatic nerves in mice, it was proposed that JNK acts via activation by the 
dual leucine kinase (DLK) to promote axonal degeneration (Miller et al., 
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2009). Moreover, it was suggested that JNK is needed at the early stage of 
degeneration before an axon is committed for final breakdown (Miller et al., 
2009). Previously, it was reported that presence of p-JNK in the cell soma of 
the injured neuron is dependent on both time and the distance from the 
injury (Kenney and Kocsis, 1998).   
Microtubule disassembly is one of the hallmarks of Wallerian 
degeneration (Coleman, 2005). The JNK substrate SCG10 has recently been 
described as an axonal maintenance factor, whose loss is associated with the 
early stage of axonal injury. Moreover, the absence of SCG10 allows 
progression of the axonal degeneration mechanism (Shin et al., 2012). 
Looking into a wide range of various neurological disorders, it becomes more 
obvious how devastating the loss of an axon is for maintaining normal life. 
Therefore it is crucial to seek for the mechanism behind the observed 
degeneration that in turn may reveal potential therapeutic targets in the 
future.  
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OBJECTIVES 
My PhD project focused on defining the function of SCG10 phosphorylation 
by JNK in neurons. The questions we set to answer concerned both 
physiological and pathophysiological conditions.  
The main goals established for studies I-III were:  
1. To determine the role of JNK1 in regulation of its bona fide target 
protein SCG10 in regulating neurite growth. (Study I)  
2. To elucidate the importance of the “JNK1-SCG10 duo” in orchestrating 
the early stages of neuronal migration. (Study II)  
3. To investigate if JNK1 and SCG10 regulate GA biogenesis under resting 
conditions and following pathological excitotoxic stimuli. (Study III)  
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EXPERIMENTAL PROCEDURES 
The following section contains a brief description of the materials and methods 
used during the thesis progress. More detailed information concerning specific 
experiments can be found in the original publications (I-III)  
1.  Plasmids 
For preparation of shRNA constructs the oligonucleotide UCU AGC UGC 
UAU CAU UGA AUU CAA GAG AUU CAA UGA UAG CAG CUA GAU 
UUU UU containing sense and antisense siRNA targeting rat scg10 was ligated 
into pSilencer 1.0 according to the manufacturer’s instructions. Insensitive to 
silencing mutants of SCG10 WT (i) and SCG10 S62D/S73D (i) were prepared using 2 
step PCR reaction with following primers: rSCG10i (+) 5’-aagg aaaaccgtga ggct 
aac ctg gca gca ata ata gag cgtct gcaggaaaaggagag-3’ rSCG10i (-) 5’ctctcctttt 
cctgcagacg ctctattatt gctgccaggt tagcctcacg gttttcctt-3’ Final products were 
inserted into EcoRI site of pCAGGS. To create GA targeted chimera of active 
JNK a fragment of N-terminal domain of rat scg10 was ligated upstream to 
MKK7-JNK1 (a kind gift from Roger Davis). For short targeting sequence 10 aa 
was used (mayke kmkel) for long targeting sequence 33 aa were used (mayke 
kmkel smlsl icscf ypepr niniy tyd) based on (Lutjens et al., 2000). For 
visualization purposes chimera was cloned into pEGFP-N1 vector.  
2.  Antibodies 
Antibody  Type  Vendor Application  
p-SCG10  Rabbit polyclonal Coffey lab/raised against 
EAPRTLAS(PO3)PKKKDLSLEE 
WB  
SCG10  Rabbit polyclonal Coffey lab/ raised against GST-SCG10  WB, IHC  
GM130  Mouse monoclonal Transduction Laboratories WB, IHC  
P115  Mouse monoclonal Transduction laboratories WB, IHC  
pJNK (Thr183/T yr185) Rabbit polyclonal New England Biolabs WB  
JNK1  Mouse monoclonal Pharmingen WB  
panJNK  Rabbit polyclonal Upstate Biotechnology WB  
β-tubulin III (TuJ1)   Mouse monoclonal Nordic BioSite IHC  
BrdU  Mouse monoclonal Calbiochem IHC  
Ki67  Rabbit polyclonal Novocastra IHC  
CSPG  Mouse monoclonal Sigma; St.Louis, MO, USA IHC  
TbrI  Rabbit polyclonal Millipore/Chemicon IHC  
p-c-Jun (KM-1) Mouse monoclonal Santa Cruz WB  
GFP (JL-8)  Mouse monoclonal  BD Biosciences Clontech WB  
Histone pS28  Rat monoclonal Pharmingen WB, IHC  
BrnI  Guineapig polyclonal Kind gift from Dr. A.Ryan IHC  
dsRed-1  Mouse monoclonal Clontech WB  
WB-Western Blot, IHC- Immunohistochemistry  
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3.  Special reagents 
The NMDA receptors agonist N-methyl-D-aspartic acid was from Research 
Biochemicals Inc (RBI). JNK peptide inhibitor DJNK1 was purchased from 
Genecust. Kinase inhibitors SP600125 and SB203580 were purchased from 
Calbiochem (San Diego, CA). Hoechst 33342 nuclear dye together with 
mounting medium (Mowiol) was from Hoechst Marion Roussel (Frankfurt, 
Germany).  
4.  Cell culture 
4.1  Primary cell culture 
Cortical neurons were prepared from newly born Sprague Dawley rats (P0) 
or from C57/B6J wt and Jnk1-/- mice. Both rats and mice were decapitated and 
cortices were dissected in a medium containing kynurenic acid to prevent 
activation of NMDA and AMPA/kainic receptors. Dissected cortices were 
digested in a papain solution (100 U) from Worthington (#3119). The enzyme 
activity was blocked using Trypsin Inhibitor (100 mg) (Sigma, Type IIL). 
Cortices were gently triturated to avoid unnecessary cell damage. Cells were 
grown on glass coverslips coated with poly-D-lysine provided by BD 
Biosciences (#354210). Rat cortical neurons were plated in MEM medium 
containing 10% fetal calf serum, 30mM glucose, 2mM glutamine, and 
penicillin/streptomycin (50 U/50 μg/ml). Whereas mouse cortical neurons 
were grown in Neurobasal medium (Gibco) supplemented with B27 50x 
(Gibco ™ # 17504044), and 2 mM glutamine. 900.000 cortical neurons (rat) 
and 750.000 cells (mouse) per well were plated in 24 well plates. Within 48 h 
post plating 50% of growth medium was exchanged for a fresh medium 
supplemented with 2.5 μM cytosine arabinofuranoside (Sigma) to reduce 
non-neuronal cell proliferation.  
4.2  Cell lines: COS7, HEK293T 
COS7 cells were grown in Minimal Essential Medium (Invitrogen) 
supplemented with 10% (v/v) fetal calf serum (FCS), 2mM glutamine, 50 
U/ml penicillin and 50 μg/ml streptomycin. HEK293T were cultured in 
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Dulbecco's Modified Eagle Medium (Invitrogen) supplemented with 10% 
(v/v) FCS, 2mM glutamine, 50 U/ml peniclilin and 50 μg/ml streptomycin.  
All cell cultures were grown in a humidified 5% CO2 incubator at 37°C.   
5.  Transfection methods 
5.1  Primary cell culture 
Cortical neurons were transfected with a Lipofectamine 2000™ reagent 
(Invitrogen). Ratio of DNA: LF2000™ was 0.5 μg: 1μl to avoid increased 
toxicity. For experiments followed by NMDA treatment cells were 
transfected at 6 DIV, 48h prior to excitotoxic insult. For gene silencing 
experiments using shRNASCG10 cortical neurons were transfected 72 h prior 
additional treatment to ensure sufficient knockdown effect.  
5.2  Cell lines: COS 7, HEK 293T 
COS7 cells were transfected with a Lipofectamine 2000™ (Invitrogen) 
reagent. Cells were plated in a 24 well plate 24 h prior transfection.  The 
expected cell confluency on the day of transfection was 60-80%. 400 ng of 
DNA and 1.2 μl of Lipofectamine was used in the assay maintained in 24 
well plates. DNA-Lipofectamine mix was diluted in 40 μl MEM/10 mM 
Hepes and incubated for 30min at room temperature. Cells were prewashed 
with MEM/10 mM Hepes prior DNA mix addition. 6 hours post 
supplementing DNA complete COS 7 cells medium was added in an equal to 
transfection volume and cells were grown for additional 20-48hours.  
HEK 293T cells were transiently transfected using calcium phosphate 
precipitation method.  Similarly to COS 7 HEK 293T cells were re-plated 24 h 
prior transfection. The expected cell density on the day of transfection was 
50-60%. DNA in the amount of 0.5 μg was diluted to 450 μl in water and 
mixed with 50 μl of 2.5 M CaCl2. Prepared mix was pipetted into swirling 
HeBS buffer (274 mM NaCl, 10mM KCl, 1.4 mM Na2HPO4*7H2O, 15 mM D-
Glucose, 42 mM Hepes-free acid, pH 7.2) and left for additional 30 min at 
room temperature to allow precipitate formation. Finally cells were grown 
for additional 24-48 h after DNA mix was dripped onto them.  
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6.  Immunostaining 
6.1  Immunohistochemistry of cultured cells 
Cortical neurons grown on coverslips were fixed with 4% paraformaldehyde 
for 15 min at room temperature. Thereafter cells were permeabilised with 
phosphate buffer saline (PBS) containing 1% Triton for 2 min. Thoroughly 
washed with PBS cells were blocked for unspecific binding of the antibody 
with 10% fetal calf serum (FCS) containing 0.2% Tween 20 for 1h at room 
temperature. Primary antibody diluted in 1% FCS/PBS was incubated over 
night at +4°C (1:1000 for GM130, 1:1000 for SCG10, 1:1000 for p115, 1:5000 for 
TuJ1). Following thorough washing secondary antibodies (generally at 1:500 
for Alexa 488 or Alexa 568) were incubated for 1h at room temperature. 
Afterwards nuclei were stained using Hoechst 33342 dye (1:3000). Samples 
were analyzed with Leica DMRE fluorescent microscope.  
6.2  Immunohistochemistry of glass-mounted tissue sections 
Brains pre-labelled with BrdU were extracted from C57B6 mice and fixed by 
immersion in 4% paraformaldehyde in phosphate buffer for 24 h at + 4°C. In 
order to prepare tissues for cryosectioning tissues were moved to 30% 
sucrose buffer for 3-4 days. Afterwards tissues were swiftly frozen in 
isopentane and on the day of sectioning embedded in O.C.T compound 
(Tissue-Tek, Zoeterwoude, Netherlands). Slices (40 μm) of sagittal sections 
were collected on gelatin coated glass slides and stained with antibodies for 
BrdU 1:50 (Calbiochem) and Ki67 1:100 (Novocastra). Anti-BrdU antibody 
was detected using anti- mouse IgG 1 specific A 488 (1:500) secondary 
antibody and Ki67 was detected using antirabbit IgG specific A 568. Samples 
stained for Tbr I (1:1000) were detected using A 568. Slides were 
counterstained with Hoechst 33342. For final analysis single plane images 
were collected with Zeiss LSM510 META confocal microscope using 20x air 
objective.  
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6.3  Immunohistochemistry of tissue sections: free-floating 
technique 
Fixed brain tissue, cryoprotected either in 30% sucrose (for MCAO) or 20% 
glycerol was embedded in Optimum Cutting Temperature (O.C.T) 
compound (Tissue Tek) prior to cutting. Consecutive coronal (MCAO) and 
saggital (pilocarpine) 40 μm sections were cut on a cryostat (Microm HM500 
OM) and stored in cryoprotectant (30% ethylene glycol, 25% glycerol, 0.05M 
Na-Phosphate buffer). On the day of analysis, slices were washed 3x 10min 
with 1xTBS (50 mM TrisHCl pH 7.4, 150 mM NaCl) to remove remaining 
cryoprotectant, treated with 1% sodium borohydrate for 15 min and washed 
6 times with 1xTBS. For blocking 10% horse serum (40 min) was used. 
Primary antibody (GM130 1:1000, or p115 1:1000) was added in 1% horse 
serum. Slices were placed at +4°C in order to allow slow binding of the 
antibody. Next they were washed with 1% horse serum prior secondary 
antibody addition (A 488, Invitrogen) and left ON at +4°C. Nuclei were 
stained with Hoechst 33342.  Sections were mounted on glass slides with 
Mowiol 4-88 (Hoechst).  The MCAO tissues were a kind gift from the 
laboratory of Prof. Jari Koistinaho (University of Eastern Finland) and 
pilocarpine treated brains were kindly given by Prof. Asla Pitkänen 
(University of Eastern Finland).  
7.  SDS-PAGE and Western blot analysis 
7.1  Harvesting and processing of brain tissue/cell culture 
Protein lysates in 1x Laemmli sample buffer were subjected to SDS-PAGE 
and transferred to a nitrocellulose membrane (Hybond ECL, Amersham 
Biosciences). Membranes were blocked for 1h RT in TBST or PBST buffer 
containing 1-5% milk.  Membranes were incubated with primary antibody 
ON at +4 °C. Next day membranes were subjected to several washes and 
incubated for 1h at RT with horseradish peroxidase conjugated secondary 
antibody. Secondary antibody was used at concentrations 1:50 000-1:200 000 
in 1-5% milk TBST/PBST buffer. The signal was detected with West Femto 
SuperSignal (Pierce).  
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8.  Animal experimentations 
All animal procedures were conducted in accordance with the guidelines 
provided by European Community Council Directives 86/609/EEC replaced 
during the thesis progress by Directive 2010/63/EU. Each experiment had the 
approval of the National Animal Experiment Board (ELLA). In designing our 
experiments we followed the 3R’s ethical principle to refine, reduce and 
replace animal use when possible. All embryos used in this study originated 
from matings between inbred C57BL6J mice. Mice were mated over night 
and early in the morning the following day female mice were examined for 
presence of vaginal plug. Mice positive for the plug were marked as 0.5 post 
coitum (p.c) and remained under strict observation for visible signs of 
pregnancy.  
8.1  Labelling of progenitor cells with BrdU 
For labeling of the progenitor cells pregnant mice (15.5 p.c) were injected 
intraperitoneally with 5 doses of BrdU (100mg/kg). The brains were extracted 
at P0 and fixed in 4% paraformaldehyde for 24 h, immersed in 30% sucrose 
buffer, frozen in iso-pentane and sliced sagitally with a cryostat (35 μm). 
Slices were postfixed with 70% ethanol for 30 min and RT and washed in 
phosphate buffered saline. DNA was denatured with 2M HCl for 10 min at 
RT and 30 min at 37°C after which acid was neutralised with 0.1 M sodium 
borate (pH.8.5) for 10 min at RT. The tissue permeabilisation was done in 
phosphate buffered saline containing 2% TX-100 for 15min. The unspecific 
binding of the antibody was prevented by incubation of the tissue slices in 
1% goat serum in phosphate saline buffer for 1h. Anti-BrdU antibody 
(Calbiochem #NA61) 1:50 was detected using anti- mouse IgG 1 specific A 
488 (1:500) secondary antibody. Tile images collected for analysis were 
captured with Zeiss LSM510 META confocal microscope using 40x oil 
objective.  
8.2  In Utero Electroporation 
Timed-pregant C57/B6J wt and Jnk1-/- mice 15.5 days post coitus were put to 
sleep with 4% isofluarane to induce deep anesthesia. 2% isofluarane was 
administered during the surgery to maintain stable surgical conditions. Tail 
and pedal reflexes as well as breathing rhythm were carefully observed 
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during each experiment. To provide analgesia mice were given 
buprenorphine injection (Temgesic ® 0.3 mg/ml) at dose 0.05-1 mg/kg (SC) 30 
min prior surgery. Approximately 2 cm incision in the abdominal cavity 
allowed exposure of uterine horns and access to embryos. About 1-2 μl of 
DNA was injected using a microinjection needle from Eppendorf (Sterile 
Femtotips II) into the lateral ventricle. Electroporation was done using square 
wave pulse electroporator from NEPA Gene (CUY21E) using tweezer type 
electrodes (CUY650-P5). Five electrical pulses (45 V, 50 ms) at 1s interval 
were passed through embryonic brain tissue. To ensure targeting of the 
ventricular zone area electrodes were placed at 0° angle inclination in respect 
to the horizontal plane. With no additional delay uterus was placed back in 
the abdominal cavity and embryos were left to develop to later stages. 
Muscle and skin layer were sutured separately using Silkam sutures from 
Braun.   
8.3  Organotypic cortical slice culture 
In utero electroporated C57/B6J wt and Jnk1-/- embryos were extracted 48 h 
post electroporation for purposes of organotypic slice culture. Brains were 
dissected in cold PBS/glucose and transferred into liquid 3% low melting 
agarose (38 °C) (Bio-Rad #161-3112) and kept on ice for 1 h. Embedded brains 
were cut sagittaly (300 μm) with a vibratome (Leica VT 1000S). Brain slices 
were transferred onto culture plate inserts from Millipore (Millicell CM 
#PICMORG 50) containing Neurobasal medium (Invitrogen # 12348-017) 
supplemented with 1% N2 (Invitrogen # 17502-048), 1% B27 (Gibco ™ # 
17504044), 2mM Glutamax (Invitrogen #35050-038) and 
penicillin/streptomycin (50U/50 μg/ml). Slices were cultivated under semi-
dry conditions and recovered for 4 h in the cell culture incubator prior to 
imaging.  
9.  Pharmacological treatments of time course 
experiments 
9.1  NMDA 
N-methyl D-aspartate treatment was carried out by adding 60 μM NMDA to 
8 days old cortical neurons (8 DIV) remaining in growth medium. Cells were 
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fixed (4% PFA) at designated times 15 min, 30 min, 60 min, 1 h, 4 h and 24 h. 
Samples were further subjected to immunochemistry analysis.  
9.2  DJNKI1 
The D- retroinverso peptide inhibitor of JNK kinase (DJNK1) was added to 8 
DIV cortical neurons 1h prior NMDA addition. Cells were grown in the 
presence of serum hence two concentrations of DJNK1 were used 2 and 20 
μM. Cells were fixed (4% PFA) at selected times 15 min, 30 min, 60 min, 1 h, 4 
h and 24 h post NMDA treatment. Cells were further stained according to 
immunochemistry protocols.  
10.  In vitro model of cell migration 
Neurons in Boyden chamber were transfected with g-LMKK7JNK1-GFP, 
pEGFP-GM130, gLJIPJBD-dsRed1, pEGFP-NES-JIPJBD, pEGFP-SCG10DD at 
the moment of plating using Lipofectamine 2000 (Invitrogen) protocol. Cells 
were co-transfected with pEGFP-C1 empty vector to allow better 
visualization of cells passing through the pore. After 24 and 48 h cells were 
fixed with 4% paraformaldehyde and nuclei were stained Hoechst 33342. 
Cells that remained on the inner surface (did not migrate) were removed 
using a cotton bud. The number of fluorescent cells that had migrated 
through the membrane were counted (blind) using Olympus BX100.  
11.  Microscopy 
11.1  Confocal analysis and time lapse imaging 
For timelapse experiments, C57/B6J wt/Jnk1-/- mice were electroporated at 
E15.5 with GFP and embryos were extracted at E17.5. Imaging was done with 
inserts placed on glass- bottomed dishes (MatTek #P35G-0-20-C) under 
environmental control maintained by Tempcontrol 37-2 digital (Zeiss). 
Timelapse movies were constructed from z-stack images captured at 30 min 
intervals using a Zeiss LSM510 META confocal microscope equipped with 
20x air objective (NA =0.5). Each stack was composed of approx. 25 single 
scans. Movies were recorded for 10h. Image processing was done with Image 
J free software by using Z projection with Average intensity.   
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RESULTS AND DISCUSSION 
1.  Identification and characterization of novel JNK 
effector protein SCG10 (Study I) 
Initially, JNK’s role was associated with stress functions and cell death (Ip 
and Davis, 1998, Kyriakis and Avruch, 2012). Over time however, the way 
JNK is perceived changed and it is nowadays acknowledged that JNK is also 
an important regulator of physiologically indispensable proteins (Gdalyahu 
et al., 2004, Xia and Kao, 2004, Xia and Karin, 2004, Björkblom et al., 2005). In 
the brain, JNK activity is constitutively high when compared to non-neuronal 
tissue (Hu et al., 1997, Coffey et al., 2000, Coffey et al., 2002). During early 
brain development it acts as a critical regulator of regional apoptosis (Kuan et 
al., 1999). Interestingly, an increasing JNK activity was observed during 
differentiation in cerebellar granule neurons (Coffey et al., 2000). In those 
cells, JNK predominantly localizes to the cytoplasm. Finally, the high basal 
activity among JNK isoforms was attributed to JNK1, which activity was 
reduced by 70% in brain tissues of Jnk1-/- mice (Björkblom et al., 2005). It was 
previously proposed that JNK controlled neuronal architecture (Coffey et al., 
2000, Björkblom et al., 2005). Nevertheless, the exact mechanism remained 
undetermined. Therefore in study I we undertook an approach to elucidate 
potential effectors of JNK action on neuronal morphology.   
In our search for JNK targets, we found that SCG10 interacts with JNK1 in 
a protein interaction screen using brain homogenate. SCG10 belongs to the 
stathmin family, known for their microtubule destabilizing potential 
(Antonsson et al., 1997). To check for interaction with other stathmins, all 
members of the family were cloned and subjected for pull down experiments 
with GST-JNK1. As assumed, we detected an interaction between most 
family members and JNK1 (Study I, Fig.2A). To further determine if SCG10-
JNK1 interaction takes place under physiological conditions, SCG10 
antiserum was generated and used for coimmunoprecipitation assay. Using 
this approach, we were able to demonstrate that SCG10 and JNK1 interact in 
vivo (Study I, Fig.2C).   
Protein phosphorylation is a key process in cell signaling. Serine 62 (S62) 
and Serine 73 (S73) are among the known phosphorylation sites on SCG10. 
S62 and S73 are targeted by MAP kinases (Antonsson et al., 1998, Neidhart et 
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al., 2001, Tararuk et al., 2006). We have shown that S73 was more intensely 
phosphorylated by JNK in vivo. Therefore a p-S73-SCG10 antibody was 
raised against a synthetic phosphopeptide. It was affinity purified using 
phospho-SCG10 and dephopsho-SCG10 columns and tested against 
recombinant phosphorylated and non-phosphorylated SCG10 (Study I, 
Fig.5A). We showed that purified p-S73-SCG10 antibody recognized only the 
phosphorylated form of SCG10.   
We reasoned that if JNK is indeed a key regulator of SCG10 function then 
JNK site specific phosphorylation of SCG10 should be diminished in Jnk 
deficient mice. Hence, we immunoblotted cortex from 7 days old Jnk-
knockout mice (Jnk1-/-, Jnk2-/-, Jnk3-/- and Jnk2-/3-/-) with p-S73-SCG10, 
SCG10 and JNK1/2 antibodies (Study I, Fig.5B). Interestingly, 
phosphorylation of SCG10 was reduced by 50% in Jnk1 deficient mice and to 
smaller extent in other knockouts (Study I, Fig.5C, D).  
1.1  SCG10 and JNK expression patterns overlap in tissue and cell 
level 
It has been known that SCG10 expression peaks during embryogenesis 
although its exact location and function remained unidentified (Stein et al., 
1988b). We argued that for SCG10 to be a bona fide target protein for JNK1, 
the expression profiles of the two should overlap. We found that indeed 
JNK1 and SCG10 displayed a stunningly similar expression pattern, both 
were found in the midbrain roof, the olfactory epithelium, the inferior 
colliculus, the medulla oblongata and importantly in the telencephalon 
(developing cortex) (Study I, Fig.6A). Further careful examination revealed 
that JNK1 and SCG10 were enriched in the intermediate zone of the 
telencephalon, known for the highest density of postmitotic neurons (Study I, 
Fig.6C, D). Importantly, both proteins phosphorylated (pJNK, p-S73SCG10) 
and non-phosphorylated (JNK, SCG10) were present in exactly the same 
brain area, where early differentiating neurons undertake migration, shown 
by co-labeling with TuJI (class III β-tubulin) (Study I, Fig. 6D).  
We have shown that JNK1 and SCG10 interact in vitro, while in vivo in the 
developing brain their expression profile overlaps. At the cellular level, 
SCG10 expression has been observed at the GA and in growth cones, with a 
conspicuous punctate staining along neurites (Lutjens et al., 2000, Gavet et 
al., 2002, Ozon et al., 2002, Tararuk et al., 2006). Immunofluorescent labeling 
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of cortical neurons showed that SCG10, JNK-phosphorylated SCG10 and 
active JNK displayed noticeably similar punctate labeling in neurites (Study 
I, Fig 7A). We wanted to know if pJNK and pSCG10 were colocalized in 
vesicles. We therefore applied crude cell fractionation to a postnatal day 7 rat 
brain. Using differential centrifugation, we separated cellular compartments 
permitting us to analyze protein distribution. We received several different 
fractions, which were characterized for their content. The P1 fraction 
contained non-homogenized parts of rat cortex, while the S1 fraction 
represented the pre-cleared supernatant comprised of all homogenized cell 
structures. The S1 was further subjected to next step centrifugation at which 
small vesicle and soluble proteins (S2) were separated from GA, lysosomes, 
ER, peroxisomes, endosomes and mitochondria (P2). Fractions S3 and P3 
contained soluble proteins and plasma membranes, respectively. Equal 
amounts of fractions were separated by SDS-PAGE and immunoblotted for 
the proteins of interest. If SCG10 is an in vivo JNK target it should be present 
in the same cell compartments as JNK and vice versa. The total pool of JNK 
determined by pan-JNK antibody was present in most of the fractions (S1, S2, 
P2, S3) (Study I, Fig.7B). Conversely, active JNK (p-JNK) strictly co-localized 
with SCG10 in the vesicular fraction (P2) enriched in GA, lyzosomes, 
mitochondria and endoplasmic reticulum.    
2.  Absence of cytoplasmic Jnk1 regulates neuronal 
migration in vitro and in vivo (Study II) 
Mice lacking a single Jnk gene grow and breed just like their corresponding 
wild type animals (Yang et al., 1997, Dong et al., 2001). Conversely, Jnk1 and 
Jnk2 double knockout mice die in utero, failing in neural tube closure (Kuan et 
al., 1999). Based on profound analysis of various combinations of Jnk1/2 
double knockouts it was suggested that Jnk1 might have a leading role in 
regulation of neural tube closure (Sabapathy et al., 1999). We have shown 
that Jnk1 basal activity is high in developing telencephalon; moreover, it 
orchestrates dynamics of MTs and neurite length via SCG10 (Study I, Fig. 6D, 
9, 10). Earlier studies in non-neuronal systems indicated that JNK activity is 
crucial for cell migration (Xia and Karin, 2004). JNK was shown to be 
necessary for dorsal closure in the fruit fly as well as the eye-lid closure in 
mice (Kuan et al., 1999, Takatori et al., 2008). Yet its role in migration of 
neuronal cells remained undetermined. Based on our earlier study, where we 
showed that Jnk1 controls microtubule dynamics, we undertook an approach 
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to unravel if Jnk1 function may expand into the process of radial migration 
and to which extend.  
To address those questions we initially set two in vitro tests employing 
cerebellar granule neurons that are well recognized primary cell culture 
model of neuronal migration (Edmondson and Hatten, 1987). Results 
obtained from surface and transwell migration assay indicated involvement 
of Jnk1 in the process of migration (Study II, Fig.1C,D and Fig. 2 A-G). We 
further searched for lamination defects in vivo, since it may reflect prominent 
marking of migration defects (Reiner, 2013). Close inspection of E15 and E18 
mouse brains cortex from both wt and Jnk1-/- animals revealed significant 
thickness difference between genotypes. At E15, the IZ and CP were 
considerably thicker in mutant mice (Study II, Fig.3A,B,C). At E18, VZ of 
Jnk1-/- mice was decreased in comparison to wt, which was in accordance 
with thicker CP (Study II, Fig. 3G, H). All mammals share a similar pattern of 
generating cortical neurons. When placed in the proliferative pseudo-
stratified VZ, neuronal progenitors undergo massive expansion to exit the 
cell cycle, and finally become a cortical neuron (Caviness et al., 1995). Early 
proliferation and migration control both number and location of future 
cortical neurons, factors that are crucial for the functional future cortex 
(Rakic, 1988). Hence, we investigated the cell cycle exit from wt and Jnk1-/- 
mice. For that purpose we used BrdU, a thymidine analog, to label dividing 
neural precursors, and Ki67 to identify subpopulations of proliferating cells 
(Kuhn et al., 1996, Zambon, 2010). Cells that exited the cell cycle were labeled 
as BrdU+/Ki67- whereas those remaining in cell cycle were identified as 
BrdU+/Ki67+. Based on the ratio between cells leaving and remaining in 
active cell cycle we calculated a cell cycle index (Study II, Fig.S2). 
Importantly, in Jnk1-/- brains the cell cycle index was decreased by 13% in VZ 
and SVZ, indicating that more cells have exited cell cycle and committed to 
neuronal fate. This was in agreement with increased number of neurons in 
CP (Study II, Fig. 3H,I).   
To investigate if detected changes in thickness are a consequence of 
advanced migration we employed an in utero electroporation gene delivery 
method. Similarly to other techniques like e.g. BrdU labeling, this pulse chase 
method can exactly label neurons present in different cortical lamina based 
on time of electroporation (Langevin et al., 2007). This method gives an 
opportunity to target a particular population of cells both in time and space. 
This technique allows for efficient transfer of DNA into cortical precursors 
present in the VZ of the telencephalon. Moreover, visualization of cells by the 
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use of DNA-carrying genes for fluorescently-tagged proteins permits precise 
observation of migration patterns (Tabata and Nakajima, 2001). Therefore in 
order to unravel JNK’s role in migration, we electroporated E15.5 embryos 
with the GFP-tagged, compartment-specific JNK inhibitor (NLS-JIPJBD, NES-
JIPJBD) or GFP in utero and analyzed their influence on migration at 
following days E17, E19 and P2 (postnatal day 2). Interestingly, blocking the 
cytoplasmic pool of JNK with NESJIPJBD speeded up cell migration. Those 
cells reached superficial cortical layers II/III already at day E19, whereas in 
control conditions (GFP-only labeled cells) neurons achieved the same 
position at P2 (Study II, Fig.4A, C,D). On the other hand, inhibition of the 
nuclear pool of JNK had an opposite result. Furthermore, at P2, half of the 
GFP-NLS-JIPJBD positive cells remained in the ventricular zone, whereas 
only 10% of control cells stayed in the VZ at that time (Study II, Fig.4A,B,D). 
We have shown that different pools of JNK may have opposing effect on 
neuronal migration, with the nuclear pool composed typically of JNK2 and 
JNK3 isoforms having mostly stimulatory effect and the cytoplasmic pool 
(JNK1) having inhibitory influence.  
2.1  Knockdown of SCG10 speeds up neuronal migration in a 
similar fashion to Jnk1 knockout 
We have previously shown that p-Ser73-SCG10 is enriched in the IZ at E15 
and so is active Jnk1 (Study I, Fig.6D). We previously postulated that Jnk1 
controls microtubule dynamics via SCG10, and hence regulates axodentritic 
length. In D. melanogaster, which has only one stathmin gene (D-stathmin), it 
was demonstrated with a knockdown approach that the absence of stathmin 
leads to serious anomalies and migration irregularities (Ozon et al., 2002). 
Hence we undertook a similar approach to investigate SCG10’s role in 
migration and transfected neurons with short hairpin RNA (shRNA) 
targeting SCG10. Interestingly, we observed a significant increase in 
migration rate in the absence of SCG10 (Study II, Fig. 5H). Moreover, this 
increase was strikingly similar to that observed when Jnk1 was 
downregulated (Study II, Fig.2C, E). Notably, there was no additional rise in 
migration rate upon inhibition of JNK with NES-JIPJBD (Study II, Fig.5H). 
Based on the results obtained, we concluded that both proteins JNK1 and 
SCG10 may share a common pathway involved in regulation of neuronal 
migration. Furthermore, expression of a double alanine mutant of SCG10 
(SCG10S62A/S73A), a mutant that cannot be phosphorylated by JNK, increased 
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migration rate in the in vitro assay (Study II, Fig.5I). Similarly, an increased 
pool of free tubulin, induced by overexpression, had comparable outcome 
(Study II, Fig.5H).   
Therefore we proposed a tentative model explaining Jnk1 and SCG10’s 
role in regulation of neuronal migration. It was previously suggested that 
SCG10 induces catastrophe at the minus end and growth at the plus end 
(Manna et al., 2007). Induced depolymerisation increases the pool of free 
tubulin, which then can be used for stabilization of the plus end. When MTs 
are linked to an immobile structure, then the observed stabilization at the 
plus end could cause protrusion of the growth cone. Because Jnk1 activity in 
the developing brain is high, SCG10 subsequently phosphorylated by Jnk1 
could retard migration by inhibiting depolymerization of microtubules at the 
minus end, thus depleting the pool of free tubulin. The relationship between 
Jnk1 and SCG10 could stipulate for a system in which Jnk1 controls the 
forward movement of neurons (Study II, S1).   
2.2  Pseudo-phosphorylated SCG10 can rescue migration defects in 
Jnk1-/- brains 
Based on in vitro results indicating a role of Jnk1 and SCG10 in migration 
(Study II, Fig. 2C,E & Fig.5 H,I), we decided to perform a series of rescue 
experiments in vivo. If SCG10 is indeed downstream of Jnk1 in migration, 
then the pseudo-phosporylated form of SCG10 (SCG10S62D/S73D) should restore 
the normal rate of migration. For that purpose we electroporated E15.5 
mouse embryos with GFP-NES-JIPJBD in utero, previously shown to increase 
migration rate (Study II, Fig.2C & Fig 4A,C) along with SCG10S62D/S73D and 
without it. Careful inspection at E19 revealed that the presence of the 
pseudo-phosphorylated form of SCG10 led to complete restoration of 
advanced migration previously seen, when the cytoplasmic pool of JNK1 
was inhibited by GFP-NES-JIPJBD (Study II, Fig.6A, B). In addition, 
electroporation of SCG10S62A/S73A increased migration rates (Study II, Fig. 6A, 
B) as previously observed in in vitro migration assays (Study II, Fig.5I). 
Moreover, the observed acceleration of migration in the presence of 
SCG10S62A/S73A was accompanied by a shorter leading process (Study II, 
Fig.6A) as previously noted in postnatal cortical neurons (Study I, Fig.9B).   
Next, we investigated the role of SCG10 in migration by applying a gene 
knockdown approach in vivo. As expected, based on in vitro results (Study II, 
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Fig.5H), in the absence of SCG10, cells migrated faster reaching superficial 
layers (I-III) already by E19 in contrast to controls (GFP) (Study II, Fig.6C, D). 
For rescue purposes we used SCG10S62D/S73D insensitive to shRNA (SCG10 
DDi). The functionality of the mutant was tested in COS7 cells in the 
presence and absence of shRNA (Study II, Fig. 6E). Importantly, 
electroporation of the insensitive to silencing mutant restored normal 
migration rate (Study II, Fig.6C, D). Moreover, introducing SCG10S62D/S73D into 
Jnk1 deficient mice reestablished normal migration rate (Study II, Fig.6F).   
The increased migration observed in Jnk1-/- brains (Study II, Fig.2E & 
Fig.3) was further investigated using BrdU labelling, a more traditional 
method for tracking radial migration. BrdU was administered to pregnant wt 
and Jnk1-/- mice, 15 days pc (post coitum). Embryos were sacrificed at E19 or 
else at P0. We observed strikingly similar advancement in migration after 
BrdU labelling in Jnk1 deficient mice, as seen earlier, when using in utero 
electroporation approach (Study II, Fig.6H, I & Fig. 2E). Hence we believe 
that SCG10 is a key effector of Jnk1 in controlling neuronal migration.   
2.3  Distorted cell arrangement is present in Jnk1-/- brains despite 
lack of layering defects 
The structure of the neocortex reflects its complexity. It consists of six layers, 
each comprising a unique group of cells that are distinct in their function and 
cytoarchitecture (Bradke and Dotti, 1997, Kwan et al., 2012). Although we did 
not observe any clear layering defects in Jnk1-/-, cell organization was to 
some extent disordered. Immunofluorescent analysis of wt and Jnk1 deficient 
brains revealed that at E17.5 neurons forming layer VI displayed an 
elongated and crowded appearance in the mutant mouse (Study II, Fig. 7A, 
B). Moreover, further investigation of subplate layer using chondroitin 
sulphate proteoglycan (CSPG) showed that in Jnk1-/- this layer is less clearly 
defined (Study II, Fig.S2A). We have furthermore checked if Jnk1-/- neurons 
reach the cortical plate before control cells in the wt brains. Indeed we were 
able to detect more neurons restricted to superficial layers (II-III) in Jnk1-/- 
than in wt using Brn-1, a specific layer II-III marker. This was again in 
agreement with higher migration rate seen earlier in Jnk1-/-.  
The subplate forms early during development of the cortex and comprises 
the first generated neurons. Abnormalities in the subplate have been linked 
to some developmental disorders including schizophrenia, autism or 
  
82
attention deficit/hyperactivity disorder and dyslexia (Kostovic and Rakic, 
1990, Eastwood and Harrison, 2003, McQuillen and Ferriero, 2005). Neurons 
forming the subplate are crucial for establishing the correct wiring as well as 
functional maturation (Ghosh and Shatz, 1992, Kanold, 2009). Despite our 
general focus on late-born neurons (labeled at E15.5) the disruption of the 
subplate and layer VI in Jnk1-/- mice suggests that Jnk1 serves additional 
roles during earlier stages of migration, which in the long run may be 
connected to pathology in adulthood.  
2.4  Jnk1 -/- neurons exhibit increased migration rate and faster 
multipolar exit 
Upon completion of cell division, newborn neurons are obliged to move out 
of the VZ and migrate towards their final destination. In order to investigate 
the migration pattern of Jnk1 deficient neurons we set time-lapse imaging on 
the electroporated in utero cortical neurons. The Jnk1-/- tissues subjected to 
real-time imaging derived from middorsolateral telencephalon. The GFP-
positive cells were imaged continuously for 10 h. Interestingly, we observed 
that bipolar Jnk1-/- neurons migrated two times faster than control wt 
neurons imaged in parallel (Study II, Fig.7D,E).   
Before undertaking a bipolar morphology and moving towards the pial 
surface, neurons go through a multipolar stage, during which they 
frequently change both direction and rate of the movement (Tabata and 
Nakajima, 2003, LoTurco and Bai, 2006). Morphologically they are quite 
distinctive, as they show no fixed cell polarity and keep extending and 
retracting thin processes in multiple directions (Tabata and Nakajima, 2003). 
Having discovered the significant difference in speed between radially 
migrating Jnk1 deficient neurons and their wt counterparts, we examined the 
speed of multipolar cells. Importantly, the speed of multipolar neurons 
remained unchanged (Study II, Fig.7F). Hence we counted the proportions of 
multipolar to bipolar cells present in the IZ of both Jnk1-/- and wt mice. We 
observed a dramatic shift in proportions of multi- to bipolar neurons 
between the genotypes. In the wt brain, 75% of neurons presented multipolar 
morphology, in contrast to 25% observed in Jnk1 deficient brains (Study II, 
Fig. 7G). Likewise, the presence of GFP-tagged JNK inhibitor NES-JIP-JBD 
dramatically decreased the number of multipolar cells in the IZ (Study II, Fig. 
7H). Similarly, in utero introduction of the unphosphorylable-byJNK form of 
SCG10 (SCG10S62A/S73A) led to the same distribution of multi- to bipolar 
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neurons as observed in the Jnk1-/- brain. Conversely, presence of the 
pseudophosporylated-by-JNK form of SCG10 (SCG10S62D/S73D) reversed the 
phenotype previously observed in SCG10S62A/S73A electroporated cells (Study 
II, Fig. 7G). Furthermore, we counted proportions of cells, which left the 
multipolar state and acquired bipolar morphology during the 10 h recording. 
It was done in order to discriminate between cells, which transitioned more 
rapidly from the multipolar state, and those that bypassed it. Unlike wt 
multipolar cells, which in the great majority kept their multipolar 
morphology through the 10 h monitoring period, the Jnk1-/- multipolar 
neurons mostly transited into bipolar (Study II, Fig.7J).   
These results indicate a key role of JNK1 in regulating both speed and 
multi- to bipolar transition, which in turn leads to advanced translocation of 
neurons during brain development. Moreover, it also implicates SCG10 in 
the regulation of multipolar transition.  
3.  JNK1 and SCG10 are important regulators of Golgi 
apparatus function (Study III) 
Microtubules are key elements of neuronal morphogenesis in the developing 
brain. Both neuronal migration and polarization depend on proper function 
of MTs (Barnes and Polleux, 2009, Conde and Cáceres, 2009). The particular 
shape and size of neurons exerts unusual demands on them, hence the 
organization and nucleation of MTs has to be precisely regulated to maintain 
such complex arrays (Desai and Mitchison, 1997). The Golgi complex plays a 
central role in protein sorting and secretion, but also serves as a potential 
source of microtubule nucleation (Presley et al., 1998, Efimov et al., 2007). 
Interestingly, upon treatment with the cytoskeletal drugs nocodazole, 
fragmented GA cisternae can still actively promote nucleation of 
microtubules (Efimov et al., 2007, Rivero et al., 2009).  
We have demonstrated that SCG10, a potent microtubule destabilizing 
protein, is an in vivo substrate for JNK1. Moreover, we have shown that JNK1 
can regulate axodendritic architecture in cortical neurons by phosphorylating 
SCG10. Moreover, JNK1 acting via SCG10 negatively regulates radial 
migration. In addition, active SCG10 is highly concentrated at the GA, with 
p-JNK1 simultaneously being excluded from that area. To date the role of 
SCG10 in maintenance of GA stacks has remained undetermined. Therefore, 
we investigated a role for JNK and SCG10 in preservation of GA biogenesis. 
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In addition, since both JNK and SCG10 are involved in neurodegenerative 
processes (Anderson et al., 1994, Okazaki et al., 1995, Borsello et al., 2003, 
Wang et al., 2013) we examined if pathological JNK action may be manifested 
by deregulated GA structure.   
Because the GA form is maintained by MTs we initially screened cultured 
cortical neurons for the most commonly appearing, representative GA 
morphologies detected under physiological conditions.  
We observed a vast range of distinct GA shapes ranging from loose to 
highly elongated ones, constricted to one long tubule. Based on microscopic 
analysis we grouped observed morphologies into four different groups (I to 
IV). Group I neurons were characterized by somewhat elongated reticular 
Golgi, neurons in group II had (more) compact fragmented Golgi, group III 
neurons had very compact juxtanuclear Golgi, while group IV contained cells 
with characteristically highly elongated Golgi. In order to address a role for 
JNK1 in Golgi morphology, we used wt and Jnk1-/- mouse neurons and 
grouped cells accordingly. To our surprise we noticed that the number of 
neurons falling into group IV (highly elongated Golgi) was significantly 
decreased in Jnk1-/- in comparison to wt (Study III, Fig. 1 B). At the same 
time, to investigate the role of SCG10 in maintenance of GA morphology, we 
used a gene knockdown approach with shRNA targeting SCG10. The 
absence of SCG10 resulted in an apparent loosening of the GA complex, as 
more cells displayed very compact juxtanuclear type Golgi (group III) and 
fewer highly elongated Golgi (group IV) (Study III. Fig. 1 C).  Similar to Jnk1-
/- cells, the absence of SCG10 led to less compact GA morphology (Study III, 
Fig.1B, C).   
In mammalian neurons and also in D. melanogaster neurons, the GA 
localized to the GA cisternae and the so-called Golgi outposts that exist in 
dendrites (Gardiol et al., 1999, Pierce et al., 2001, Horton and Ehlers, 2003). 
Their structure is maintained by a highly dynamic array of microtubules, 
serving as tracks for directed vesicular transport and sustaining both antero- 
and retrograde protein transport between the endoplasmic reticulum and the 
GA (Trucco et al., 2004, Horton et al., 2005, Ye et al., 2007, Hoogenraad and 
Bradke, 2009, Stiess et al., 2010). We have previously proposed that SCG10 is 
predominantly localizing to the GA compartment in its dephosphorylated 
state (Study I). As there is a continuous flow of vesicles between the ER and 
the GA, we wondered if SCG10 together with JNK could be involved in 
orchestrating ER to GA transport. To test this, we used Brefeldin A (BFA), 
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which acts by blocking ADP-ribosylation factor protein 1 (ARF1), a GA 
associated guanine nucleotide exchange factor (Helms and Rothman, 1992, 
Donaldson and Lippincott-Schwartz, 2000). ARF1 is a key player in vesicular 
traffic from the ER to the GA. Blocking its action eventually leads to 
redistribution of GA complex proteins into the ER exit sites (Dascher and 
Balch, 1994, Elazar et al., 1994). Importantly, removal of the drug 
reestablishes GA cisternae (Lippincott-Schwartz et al., 1989). Pretreatment of 
mouse cortical neurons with BFA resulted in different recovery responses in 
wt and Jnk1-/- neurons (Study III, Fig. 2A,B). Importantly, cells lacking Jnk1 
recovered structural integrity of the GA at a slower rate than wt neurons 
(Study III, Fig.2B).  We have previously noted that Jnk1-/- neurons were 
characterized by less compact GA structure and as were SCG10 depleted 
cells (Study III, Fig. 1B,C). As SCG10 is a potent microtubule destabilizing 
protein we wanted to know if it plays a role in GA recovery, hence we 
transfected cells with shRNA SCG10 and repeated BFA treatment. 
Interestingly, SCG10- depleted cells were unable to complete recovery of GA 
stacks reaching their baseline of vesicular GA at 4 h, unlike control cells 
which recovered their stacks much more efficiently (Study III, Fig. 2C,D).  
3.1  Golgi fragmentation in response to excitotoxic insult involves 
both JNK1 and SCG10 
JNK has been well established as a stress-activated kinase leading to 
transcriptional regulation and cell death (Kyriakis and Avruch, 2012). Hence, 
we tested whether activation of JNK at the GA could underlie SCG10-
mediated GA dysregulation and play a role in neuronal stress responses. It 
was previously observed that some upstream JNK activators (Akr1p-like 1 
and 2, MUK/DLK) localize on the outer face of the GA (Douziech et al., 1999, 
Harada et al., 2003). Importantly, active JNK itself is excluded from the GA 
region. To test if disregulated JNK activity at the GA is sufficient to disturb 
GA integrity we brought active JNK (MKK7-JNK1) to the GA compartment. 
We used the Golgi-localizing sequence of SCG10 (Charbaut et al., 2005) and 
fused it upstream from MKK7-JNK1 (Lei et al., 2002). Targeting of active JNK 
to the GA resulted in a strong GA fragmentation (Study III, Fig. 3C).   
Given that GA fragmentation has been reported in stroke and 
neurodegeneration (Vizi et al., 2012) and the important role of JNK in stroke 
(Borsello et al., 2003, Hirt et al., 2004, Gao et al., 2005, Borsello et al., 2007), we 
examined the time-course of NMDA-induced GA fragmentation in cultured 
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neurons. We treated cortical neurons with 60 μM NMDA to induce hyper-
activation of NMDA receptors. In control cells, the GA was localized at the 
peri-nuclear region, organized as a collection of well-defined cysternal stacks.  
We observed a mild fragmentation as quickly as 15 min post NMDA 
addition. We noticed that GA fragmentation proceeded in a time-dependent 
manner, starting from a nicely structured compartment, the GA fragmented 
into tiny particles within 1 hour of NMDA treatment (Study III, Fig. 4A). At 
the same time as shown in Fig. 4B, Study III, around 80% of cells died within 
24 h.  
We further examined the role of JNK1 in NMDA induced fragmentation 
of the GA in particular. For that purpose we used cortical neurons from wild 
type and Jnk1 knockout mice. NMDA treatment revealed partial but 
significant delay in GA fragmentation in Jnk1 deficient cells compared to 
wild type (Study III, Fig. 5A). We have repeated NMDA treatment on cells 
depleted of SCG10 (shRNA SCG10 transfected cells) and noticed that the 
fragmentation of the GA was also significantly retarded, suggesting that 
SCG10 is instrumental in NMDA-induced disruption (Study III, Fig.4C). 
Together, these results imply that NMDA-induced JNK may trigger SCG10-
induced GA fragmentation. It was previously suggested by Nakagomi and 
co-workers that GA may serve as a sensor for death signals and various types 
of cellular stress like excitotoxicity, reactive oxygen species or ER stress 
irreversibly fragment the GA (Nakagomi et al., 2008). At the same time 
blocking GA fragmentation in non-neuronal cells entering mitosis blocks cell 
division (Sutterlin 2002). Interestingly Thayer et al., (2013) proposed that GA 
fragmentation in response to stress can be a reversible process. In their study 
they used elevated potassium, which led to GA fragmentation in 
hippocampal neurons. However this process was reversed upon returning 
cells to low potassium medium. This raises a possibility that GA 
fragmentation could be a transitional state before commencing to death. The 
fact that SCG10 and JNK1 both delay GA fragmentation could suggest a role 
for them in promoting cell survival, however upon longer stimulation with 
NMDA the death promoting signaling pathway take over and neurons die in 
result of excitotoxic stimulation.  
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3.2.  Hyperactivation of NMDA receptors leads to Golgi 
fragmentation in vivo in animal models of diseases involving 
JNK activation 
It has recently been observed that the GA undergoes fragmentation in a 
variety of neurodegenerative disorders including ALS, AD, Creutzfeldt-
Jacob’s, Huntington’s disease, corticobasal degeneration as well as 
spinocerebral ataxia type 2 (Mourelatos et al., 1990, Stieber et al., 1996, 
Sakurai et al., 2000, Huynh et al., 2003, Gonatas et al., 2006). Importantly, the 
disease onset is only noticed years later (Gonatas et al., 2006). Given that we 
detect a substantial disruption of the GA in cultured cortical neurons 
following NMDA treatment, we wanted to examine GA integrity in animal 
models of excitotoxicity, namely stroke and epilepsy. Therefore, we 
monitored GA fragmentation in the MCAO model of stroke and in the 
Pilocarpine-induced status epilepticus (SE), both of which mimic disease states 
resulting from hyper-activation of NMDA receptors (Rice and DeLorenzo, 
1998, De Angeli et al., 2009). Microscopic analysis of mouse brain, where one 
MCA was electro-coagulated and the other remained unaffected, revealed 
profound GA fragmentation in the infarct region already within 30 min. 
Conversely, in the contralateral side where the middle cerebral artery was 
unaffected, so was the GA (Study III, Fig. 6A,B). The sham-operated animal 
showed no evidence of disturbed GA structure (Study III, Fig. 6C). We have 
further investigated the protein expression profile after MCAO. For that 
purpose a small part of brain tissue from the MCAO region and a matching 
piece from the contralateral side were excised and subjected to western blot 
analysis. By 4h post-occlusion, we observed increased levels of SCG10 
protein as well as an additional band of about 90 kDa in a GM130 blot, 
possibly representing a proteolytic cleavage product (Fig.6D). Moreover, we 
have also noticed increased activity of JNK (pJNK blot) and phosphorylation 
of its target protein c-Jun. These data show that GA fragmentation occurs in a 
well-characterized stroke model, indicating that disassembly of the GA is a 
feature of hyperactivation of glutamate receptors in vivo in the cortex.   
The first clear indication that JNK was involved in excitotoxicity came 
from Jnk3 knockout mice, which presented with reduced seizures as well as 
decreased cell death in response to systemic administration of kainate (Yang 
et al., 1997). It is well known that the hippocampus, among other regions 
such as the endopiriform nucleus, piriform cortex and claustrum, is one of 
the most affected brain regions following excitotoxic insult (Scorza et al., 
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2009). Therefore we investigated whether GA degradation occurred in the 
hippocampus following status epilepticus. The inspected brain tissues 
revealed profound GA fragmentation as soon as 30 min following 
pilocarpine treatment within the hilus area of the dentate gyrus, CA3 and 
CA1 region compared to control brains, where the GA remained unchanged 
(Study III, Fig. E).  Although pilocarpine induces cell death within hours post 
administration, SE-animals live and behave normally (Schauwecker, 2012). 
The level of observed fragmentation indicates a general feature of cells from 
the inspected regions. Moreover, we have previously shown that both SCG10 
and JNK1 show comparable localization in brain regions known for their 
regenerative capacity. Both are present in pyramidal cells of the CA1 and 
CA3 as well as granule cells of DG in the hippocampus (Westerlund et al., 
2008). However, it remains to be seen if JNK1 or any JNK isoform contributes 
to GA restoration following excitotoxic insult in vivo.  
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CONCLUDING REMARKS 
This thesis was dedicated to furthering our understanding of the JNK1 and 
SCG10 function in the brain. We provided evidence that SCG10 is a bona fide 
target for JNK1, although JNK3 was also shown to phosphorylate SCG10 
(Neidhart 2001). Hence a new physiologically essential function in regulation 
microtubule dynamics could be attributed to a key kinase, JNK1.  
Microtubules are key elements of the eukaryotic cytoskeleton. They take 
part in diverse cellular functions including cell migration, polariztion, cell 
division or else intracellular trafficking. They originate at the centrosome, 
which serves as a microtubule-organizing center. Microtubule are 
characterised by their dynamic instability as shown by alternating cycles of 
growth and shrinkage separated by catastrophe and rescue events (Desai and 
Mitchison, 1997). Interestingly, cellular structures like the nucleus or the GA 
can also function as sites for nucleation of specific microtubules 
subpopulations (de Forges et al., 2012).   
For neurons to grow long axons and dendrites, it requires strict control 
over the dynamics of microtubules. Therefore, accidental disassembly would 
easily impede outgrowth (Dent and Getler, 2003). We believe that JNK1, by 
blocking SCG10 destabilizing activity via phosphorylation events, can 
provide this stabilizing effect to extending neurites and therefore regulate the 
axodentritic architecture of cortical neurons (Study I).   
It has been shown that SCG10 expression levels peak in the embryonic 
brain and decline after birth (Stein 1988). Importantly, neurite extension is 
one of the characteristic features of migrating neurons in the developing 
brain (Rakic, 1972). While we have shown that SCG10 is an important 
regulator of neurite growth (Study I) we have furthermore shown that SCG10 
is also a new and important player in the process of radial migration in the 
developing brain (Study II).  Knockdown of SCG10 significantly speeded up 
radial migration, as did the absence of Jnk1 in knockout animals. In addition, 
exogenous expression of pseudophopshorylated SCG10 restored the 
migration defect noticed in Jnk1-/- mice. So did the presence of the JNK-
specific inhibitor JIP-JBD. We have furthermore disclosed an additional role 
for JNK1 and SCG10 during earlier stages of neuronal migration, namely 
their involvement in multipolar transition (StudyII).   
  
90
Finally, we have shown that the JNK1-SCG10 duo regulates the biogenesis 
of the GA complex. Depletion of either JNK1 or SCG10 affects its 
morphology and significantly impairs restoration of GA cisternae following 
BFA treatment. Moreover, we showed that either knockdown of SCG10 or 
knockout of Jnk1 results in delayed GA fragmentation upon excitotoxic 
insult. This implies that JNK1 and SCG10 may also act as important 
regulators of microtubule dynamics within the close vicinity of the GA 
compartment under specific conditions.  
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